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Abstract 
An important requirement for dental materials placed in direct contact with living 
tissues is the regeneration or repair of those surrounding tissues. Mineral Trioxide Aggregate 
(MT A), a cement-type material introduced in the dental field in the mid 1990s, has gained 
much popularity. MTA was initially recommended as a root-end filling material or a 
perforation repair material. It has since been widely investigated for its variety of potential 
vi 
applications such as an apical barrier in teeth with immature apices, repair of root perforation, 
root-end filling, direct pulp capping and pulpotomy. Studies have demonstrated that MTA is 
a unique material because. of its ability to promote regeneration of periradicular tissues 
(Schwartz, Mauger et al. 1999; Torabinejad and Chivian 1999; Giuliani, Baccetti et al. 2002) 
and superior biocompatibility (Torabinejad, Hong et al. 1995; Torabinejad, Pitt Ford et al. 
1997). 
Tissue regeneration is an important characteristic for a material to be suitable in 
endodontic surgical procedures or for other procedures where living tissues are directly 
involved. In order to improve regeneration potential, researchers have looked at ways to 
stimulate osteogenic activity when a bone defect was detected adjacent to the sealing material. 
Ions released from various materials were found to stimulate osteogenic activity. 
Silicon ion was demonstrated to ·have osteogenic potential. Silicon ion can be released from 
bioactive glasses and serves as a signal for osteoblasts. In the Biomaterial Laboratory of Dr. 
Chou at Boston University, the effects of such silicon ions are being investigated. An 
addition of 15% silicon by weight to MTA was previously reported for its osteogenic effects 
on osteoblast cells (Dr. Tam et al.). Various percentage of silicon added to the MTA or other 
ions, such as calcium, were however not investigated for their potential in further stimulating 
osteogenic re~ponses in human osteoblast cells. 
In the in vitro study herein reported, two different modifications were made to 
conventional white MTA. The first one consisted of the addition of 30% Silicon (SiO2) by 
weight to the MTA powder (MTA+Si). The second one consisted of the addition of 30% 
Bioactive Inorganic Element (BIE) by weight to the MTA powder. This second modification 
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added 6% Si and 4.5% Ca by weight to the MTA. The abbreviation MTA+BIE is used to 
\ 
describe this mo~ification. Silicon and Calcium are two elements known for their ability to 
signal and selectively stimulate osteogenic activity. 
The objectives of this study were to examine the effects of MTA and modifications 
made to MTA on pH of the culture medium, alkaline phosphatase (ALP) activity, osteocalcin 
expression, cell attachment and proliferation. MTA, MTA+Si, and MTA+BIE were prepared 
and condensed into 24 well-plates and allowed to set for 24h at 37°C and 100% humidity. 
Human osteoblast-like cells were grown from human bone explants to second passage, 
transferred and cultured in the presence of the test materials. Human primary osteoblast cells 
were chosen for this study instead of osteosarcoma cell lines because there are alterations in 
the underlying biological regulatory mechanisms of osteosarcoma cells that may be 
_ fundamentally different from primary osteoblasts from normal bone. To serve as control, a 
group received cells that were cultured directly on the culture plate ( cells only group). The 
culture medium was collected on day 1, 4, 7, 10, 12, 13, 16, 18 and 20. Cell attachment and 
proliferation rate was determined by measuring the optical density of crystal violet dye at 16 
hours for cell attachment, and 12 and 20 days for cell proliferation. ALP was determined by 
measuring the optical density of released p-nitrophenol at 12 and 20 days. Osteocalcin 
expression was determined by measuring 1125 labeled antibody in extracted culture medium at 
12 and 20 days. 
The analysis of the results revealed that there was a drop in the pH at day 7, the values 
were the same as they were at the beginning of experiments at day 10, and then they slowly 
decreased to reach their lowest point at day 19 and their highest point at day 20. Overall, the 
pH of the groups followed the pH of the culture medium, with slightly smaller values for the 
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test materials with cells growing on their surface compared to the test materials without cell 
cultures. 
No statistically significant difference among the MTA, MTA+Si and MTA+BIE for 
the cell attachment efficiency at 16 hours and 20 days was observed. However, a statistically 
significant difference between the MTA+BIB and the MTA regarding the number of cells 
attached to their surface at 12 days was measured; the MTA having higher numbers. No 
statistically significant difference was found between the MTA and MTA+Si or between the 
MTA+Si and MTA+BIE. In observing the proliferation rate at 12 days, a statistically 
significant difference was found between the MTA and the MTA +BIB and between the MT A 
and the cells only group, the MT A having a higher proliferation rate in both cases. At 20 
days, no statistically significant difference in the proliferation rate was observed in all three 
test groups and control group (cells only). 
At 12 days, there was no statistically significant difference between the MTA, the 
MTA+Si and the MTA+BIE groups in respect to their alkaline phosphatase activity, but there 
was a statistically significant difference between the cells only and the MTA, and the cells 
only group and MTA +Si, ALP activity being higher for the cells only group. At 20 days, no 
statistically significant difference among the MT A, the MTA +Si and the MT A +BIE groups 
· was seen. The only difference was found between the test materials and the cells only group, 
the cells only group having higher ALP activity. 
At 12 days, there was no statistical significant difference among the MTA, the 
MT A +Si and the MT A +BIB groups, but there was a statistically significant difference with 
the cells only group, the latter expressing osteocalcin at a higher level. At 20 days, the same 
ix 
trend was observed, but no statistically significant difference was found among the three test 
groups and the control group (cells only). 
Results for this in vitro study support an improved osteogenic effect of normal human 
osteoblast cells grown on MTA, MTA+Si and MTA+BIE. However, no conclusion could be 
drawn as to which material had the greatest osteogenic potential. These findings are 
supported by previous studies which demonstrated that MTA is biocompatible and stimulates 
osteoblast cell expression and growth and that some elements such as Calcium and Silicon 
can also stimulate osteoblast cell expression and growth. 
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INTRODUCTION 
I 
Root canal treatment can sometimes be very challenging. Even with the correct 
diagnosis and appropriate treatment, it can lead to failure. Different approaches have been 
developed to address those situations which include surgical treatment of endodontically 
I 
treated teeth, furcal or lateral wall perforation repair and internal or external resorption repair. 
A significant number of research and clinical studies have attempted to identify the ideal 
material to be used in such complex situations. According to Gartner and Dom (Gartner and 
Dom 1992), an ideal root-end filling material should seal the apical portion of the root canal 
system in three dimensions, it should be biocompatible to minimize the inflammatory 
reaction, and non-toxic locally and systemically. It should stimulate the regeneration of the 
periradicular tissues be insensitive to moisture, and should not be absorbable by the body 
within the confines of the tooth, but excess should be absorbable. It should be dimensionally 
stable and should not corrode or stain the periradicular tissues. This ideal material should be 
~ easy to manipulate, radiopaque and adhere or bond to the tooth structure. In addition, 
regeneration of cementum, periodontal ligament, and alveolar bone across resected root-end 
surface and across the root-end filling material should be another ideal goal to achieve,-
because it is part of periradicular healing. Considering all those criteria, the main objective is 
to provide a hermetic seal of the root-canal system and to prevent the movement of bacteria 
and bacterial by-products from the oral cavity and the root canal system to the periradicular 
tissues. 
Amalgam, composite resins, zinc oxide eugenol cements (IRM and super-EBA), glass 
ionomer cements, polycarboxylate cements, cavit, gutta percha and other materials such as 
gold foil, Teflon, poly-Hema and Hydro, zinc phosphate cement and cyanoacrylate cement are 
among the materials that have been discussed or suggested as root-end filling materials in the 
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past (Friedman 1991). The biocompatibility of these materials is crucial, because they remain 
in contact with the periodontal apparatus for as long as the tooth is maintained in the mouth. 
Mineral trioxide aggregate (MT A), a recently introduced cement developed by 
researchers at Loma Linda University School of dentistry is being widely investigated for its 
variety of potential applications such as using it as an apical barrier in teeth with immature 
apices, repair of root perforation, root-end filling, direct pulp capping and pulpotomy. Studies 
have demonstrated that MT A is a very promising material because of its ability to promote 
regeneration of periradicular tissues (Schwartz, Mauger et al. 1999; Torabinejad and Chivian 
1999; Giuliani, Baccetti et al. 2002) and superior biocompatibility (Torabinejad, Hong et al. 
1995; Torabinejad, Pitt Ford et al. 1997). 
The preferred treatment of failing endodontic cases is non-surgical retreatment. 
Usually, retreatment results in successful outcomes. However, because of the complexity of 
the root canal system and the diversity of the bacterial flora that can colonize it, it may be 
difficult to achieve ideal goals with a non surgical approach. Therefore surgical endodontic 
therapy becomes the first alternative. The procedure involves getting access to the root apex, 
resecting the root-end and sealing the root canal system with a hermetic material. 
As stated previously, tissue regeneration is an important characteristic for a material to be 
suitable in endodontic surgical procedures. In order to improve that regeneration potential, 
some researchers have looked at different ways to stimulate osteogenic activity when a bone 
defect was present adjacent to the sealing material. 
Some researchers have looked at different ions released from materials for their 
poteritial to stimulate osteogenic activity. One of the ions that were demonstrated to have an 
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osteogenic potential is the element Silicon. It can be released from bioactive glass and serves 
as a signal for osteoblasts. Subtle differences in inorganic substrata can have major effects on 
cell adhesion and shape, but the molecular mechanism underlying this altered assembly 
\ 
remains unknown. Cell shape can regulate cell growth and cell differentiation. The altered 
distribution of proteins such as fibronectin that occurs may _be regulated through any 
processes from DNA transcription to the activity of the final product of protein synthesis 
(Chou, Firth et al. 1995). Another study has shown that when a higher level of Si is released 
from bioglass material which is then distributed to the area of surrounding tissues, it has a 
significant osteogenic effect resulting in a greater amount of new bone formation (Chou, Al-
Bazie et al. 1998). Based on this study, Silicon was suggested as a key element in stimulating 
osteogenesis and osteogenic activity. To support that finding, Keeting et al. (Keeting, Oursler 
et al. 1992) also came to the conclusion that the addition of a synthetic zeolite, a silicon-
containing compound, induces the proliferation and differentiation of cultured cells of the 
human osteoblast lineage. Silicon is an important trace element for the formation and 
mineralization of bone and can be added to cement as a silicon dioxide powder or it can be 
released from bioactive glasses. Other studies have also demonstrated the osteogenic 
potential of bioactive glasses and their ability to bond to living bone (Hench, Xynos et al. 
2004). Silicon released from bioactive glasses is soluble and creates ion exchanges used to 
regulate growth factor proteins and to enhance bone growth (Xynos, Edgar et al. 2000). 
Since silicon and bioactive glasses have demonstrated great potential to stimulate 
osteogenesis and have shown their potential in osteogenic regulation, the modification of 
MT A with the addition of silicon, either in silicon dioxide powder form or in a bioactive glass 
powder form, is of interest to observe whether the modified form can have a beneficial effect 
on the osteogenesis, regulation and bone markers expression of normal human osteoblast 
4 
cells. Therefore, the goal of this study is to evaluate the effects of Silicon in combination with 
mineral trioxide aggregate (MTA) on the osteogenic activity of normal human osteoblast cell 
cultures. 
5 
LITERATURE REVIEW 
6 
Basic Bone Biology 
Osteogenesis is the process of bone formation. There are three different types of 
osteogenesis: endochondral bone formation, intramembranous bone formation and sutural 
bone formation. Endochondral bone formation takes place on a cartilage matrix model, 
whereas with intramembranous bone formation, the ossification takes place within a 
connective tissue membrane. Sutural bone formation is a special form of intramembranous 
~one formation in which ossification occurs along sutural margins. 
Osteogenesis is a well balanced process that implicates diverse functions of bone 
formation, bone resorption, mineral homeostasis and bone repair (Buckwalter, Glimcher et al. 
1996). Bone cells are specialized cells with distinct morphology, function and characteristic 
location. They originate from two cell lines: the mesenchymal stem-cell line and the 
~ hematopoietic stem-cell line. The osteoblast lineage, along with the fibroblasts, the 
chondrocytes, the reticulocytes and the adipocytes lineages, originates from the mesenchymal 
stem-cell line. The osteoclast lineage, along with circulating or marrow monocytes and 
preosteoclasts, originates from the hematopoietic stem-cell line. 
The osteoblast lineage. Osteoblasts are the final stage of differentiation of a 
pluripotential stem cell in bone marrow (McCarthy and Frassica 1990). The same stem cell 
may also differentiate into marrow stromal elements such as fibroblasts, chrondroblasts and 
adipocytes. Those undifferentiated cells reside in the bone canals, endosteum, periosteum and 
marrow. They may also enter the bone by migrating from surrounding tissues or from the 
blood. They need a signal to differentiate into osteoblasts. This signal can be carried out by 
local growth factors such as Transforming Growth Factor ~ (TGF-~) and Bone 
Morphogenetic Proteins (BMPs) (McCarthy and Frassica 1990). So the stem cell is at the top 
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of the differentiation process and its fate is also controlled by a small number of growth 
factors. It is a cell that can self renew and replicate. 
In response to the growth factors, the cell differentiates into a stromal mesenchymal 
cell and is found in the marrow. At this stage, it can be induced to become an 
osteoprogenitor, once again und~r the influence of some defined growth factors. Stromal cells 
resemble periosteal cells in many ways, except for anatomical location. When the cell gets to 
the osteoprogenitor stage, it is then irreversibly committed to osteogenesis and in response to 
growth factors and hormones, it can proliferate, further differentiate or arrest. If the cell 
further differentiates, it becomes a preosteoblast and is found within newly forming skeletal 
elements. This stage of differentiation lasts 2 or 3 days (Raisz and Rodan 1990). Unlike 
osteoblasts, pre-osteoblasts retain their proliferative capacity and have begun to express early 
components of the organic bone matrix. Along with their pale-staining oval or elongated 
nuclei and their faintly acidophilic cytoplasm, the expression of those early components helps 
to distinguish them from other stromal cell precursors. The first detectable changes toward 
the differentiated state are rounding-up, organization into a contiguous layer and a rise in 
alkaline phosphatase levels. The presence of intracellular alkaline phosphatase helps identify 
these cells as osteoblast precursors. They also have receptors for 1,25(0H) 2 vitamin D and 
parathormone (McCarthy and Frassica 1990). At the osteoblast stage, the cell no longer 
proliferates, but expresses a number of matrix proteins that regulate mineral deposition. 
Osteocytes are the final stage of differentiation. They are encompassed by the mineral 
bone matrix and appear to exhibit long, neuronal-like processes that are thought to be 
involved in cell to cell communication, and perhaps sense variations in mechanical loading on 
the skeleton. 
8 
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Osteoblasts 
The osteoblast is a uninucleated cell that synthesizes both collagenous and non-
collagenous bone proteins and is responsible for its mineralization. The secreted matrix 
mineralizes about 24 hours after secretion to become the major constituent of bone tissue. 
Morphologically, osteoblasts are cuboidal cells organized as a contiguous layer above the 
matrix that they secrete. When active, they have a rounded, oval, polyhedral form and an 
osteoid seam separates them from the mineralized matrix. They have an eccentric nucleus 
that lies at the pole of the cell opposite to the secretory surface and the abundant rough 
endoplasmic reticulum, Golgi membranes and mitochondria, characteristic features of protein-
synthesizing secretory cells. 
The cytoplasmic processes of osteoblasts extend through the osteoid matrix to come 
into contact with osteocytes within the mineralized matrix (Buckwalter, Glimcher et al. 1996). 
Osteoblasts are connected by gap junctions, which may also link them to lining cells and to 
osteocytes, creating an extensive cellular network capable of electrical or cross-junction 
chemical communication. At this stage of differentiation, osteoblasts exhibit some typical 
characteristics such as their secretory products, their enzymatic profile and their response to 
hormones and other signals. They become more mature after the down-regulation of 
proliferation. Maturation occurs at which time the alkaline phosphatase gene is maximally 
expressed and the extracellular matrix is rendered competent for mineralization (Owen, 
Aronow et al. 1990). 
The most apparent function of osteoblasts is the synthesis and the secretion of the 
organic matrix of bone, but these cells may have a role in controlling electrolyte fluxes. They 
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may influence the mineralization of bone matrix through the synthesis of organic matrix 
/ 
components and osteoblasts can be stimulated to release mediators that activate osteoclasts 
(Buckwalter, Glinicher et al. 1996). Osteoblasts can be destined to become bone-lining cells, 
osteocytes or they may disappear from the site of bone formation. 
Bone-lining cells 
They are technically inactive osteoblasts or resting osteoblasts. They are the cells 
which, after bone formation is completed, are not entrapped in bone and which line the bone 
surface. Bone-lining cells have an elongated or flattened form and cytoplasmic extensions 
that penetrate the bone matrix. They have less cytoplasm and fewer organelles than do active 
osteoblasts. Although they no longer secrete osteoid, they remain sensitive to parathyroid 
hormone and vitamin D (McCarthy and Frassica 1990). Lining cells may have a role in 
.. attracting osteoclasts to specific sites and in stimulating them to resorb bone. 
Osteocytes 
As osteoblasts secrete bone matrix, some of them become entrapped in lacunae and are 
then called osteocytes. Osteocytes are the most abundant cell type of bone. The more rapid 
the bone formation, the more osteocytes are present per unit volume. As general rule, 
. embryonic (woven) bone and repair bone have more osteocytes than lamellar bone. 
Osteocytes are rounded cells with an oval nucleus and scanty cytoplasm. They are 
surrounded by bone and reside in lacunae, which are approximately 15 µm in diameter. After 
their formation, osteocytes gradually lose most of their matrix-synthesizing machinery and 
become reduced in size. A feature of osteocytes is their long, branching cytoplasmic 
processes that project from their ellipsoidal or lens-shaped bodies through canaliculi that 
extend throughout the mineralized bone matrix to come into contact with cytoplasmic 
processes from other cells. Thus, osteocytes and lining cells form a vast network of cell-to-
cell connections known as the osteocytic membrane system. 
One of the most important functions of the osteoblast-osteocyte complex is to prevent 
hypermineralization of bone by continually pumping calcium back into the blood stream to 
aid in the fine control of the serum calcium. This cell network has also the function to sense 
deformation of bone and streaming potentials occurring therein. 
Osteoclasts 
As it was mentioned earlier, osteoclasts appear to share hematopoietic stem-cell 
precursors with cells of the monocyte family. The osteoclast precursor cells may be found in 
the marrow or the circulating blood. Osteoclasts are the cells that resorb bone by enzymatic 
degradation. They are multinucleated giant cells and have a large number of mitochondria 
and lysosomes. They are usually found on the bone surface in resorption craters known as 
Howship' s lacunae or in deep resorption cavities called cutting cones. The primary feature of 
osteoclasts is the ruffled border, a specialized area of the cytoplasmic membrane adjacent to 
the bone surface. Beneath this ruffled or brushed border, there is a region of the cytoplasm 
that is free of organelles, but rich in actin filaments called the clear zone. This zone enables 
the osteoclasts to tightly affix to bone and seal off the ruffled border to form a 
microenvironment for bone digestion. Endosomes containing membrane-bound proton 
pumps move to the region of the cell nearest the bone and the pumps transport protons into 
the sealed space, decreasing the pH from approximately 7 to approximately 4. This acidic pH 
solubilizes the bone mineral. The second feature is the osteoclast's ability to secrete acid 
proteases. The proteases released from lysosomes digest the matrix proteins. The osteoclast 
11 
is characterized cytochemically by possessing tartrate-resistant acid phosphatase within its 
/ 
cytoplasmic vesicles and vacuoles. It is an important component of the hydrolytic system of 
enzymes taking part in bone resorption. 
Bone matrix 
The inorganic component contributes approximately 65% of the wet weight of bone. 
The organic component usually contributes little more than 20% of the weight and water 
contributes approximately 10%. 
Organic matrix of bone 
Collagen, predominantly type I collagen along with small amounts of type V and XII, 
makes up approximately 90% of the organic matrix. The other 10% consists of non-
collagenous glycoproteins and bone specific proteoglycans. This synthesized bone matrix 
secreted by osteoblasts is called osteoid. Collagens are fibrillar proteins composed of three 
polypeptide chains, called alpha chains, which are arranged in a triple helix. Type I collagen 
is distinguished from other collagens by its unique amino-acid content, the relatively large 
diameter of its fibrils, and its presence in tissues subjected to large tensile loads. Heritable 
abnormalities of type I collagen lead to a heterogeneous group of conditions recognized as 
osteogenesis imperfecta. 
Osteocalcin 
Osteocalcin is one of the best characterized non-collagenous proteins. Human 
osteocalcin is a 49-residue polypeptide expressed under 1,25-dihydroxyvitamin D3 control by 
osteoblasts as they actively deposit bone (Eyre 1997). This single-chain protein is also known 
as · bone gamma-carboxyglutamic acid containing protein (BGP) because of vitamin K-
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dependant, post translational carboxylation of glutamic acid residues. We can find amounts 
of 1 % to 2% of the bone protein in all vertebrae, but it comprises 10-20% of the non-
collagenous proteins of bone matrix. Osteocalcin is found only in bone, teeth and 
mineralizing cartilage. It has a strong affinity for hydroxyapatite (Robey and Termine 1990). 
Vitamin D (1,25 (OH)2D3) causes increased synthesis of this protein. The synthesis of 
osteocalcin has been shown to be stimulated by 1,25-dixydroxyvitamin D3 in vitro in rat 
osteosarcoma cells (Price and Baukol 1980), in transformed human bone cells (Beresford, 
Gallagher et al. 1984), and in vivo in rats (Price and Baukol 1981). The exact role of 
osteocalcin is not known. However, because osteocalcin is known to be chemotactic for 
osteoclasts, it may help initiate turnover. In vitro, osteocalcin serves as an inhibitor of crystal 
growth and it has been postulated to play a role in osteoclast recruitment and bone resorption. 
Its presence is not essential for mineralization to occur although it accumulates in mineralized 
bone. 
Osteocalcin is present in osteoblasts and chondrocytes in the hypertrophic zone, but 
not in preosteoblasts, suggesting that osteocalcin deposition may be a relatively late event in 
the process of bone formation (Aubin, Kursad et al. 1993). Studies have demonstrated an 
increase in osteocalcin and osteopontin expression at the onset of mineralization (Owen, 
Aronow et al. 1990). There is a general agreement that circulating osteocalcin is positively 
correlated with parameters of bone turnover, more specifically bone formation (McCarthy and 
Frassica 1990). 
Osteonectin 
It comprises about 15% of the non-collagenous bone proteins. Osteonectin is a 
phosphorylated glycoprotein that strongly binds to both collagen and apatite crystal. This 
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binding property suggests that it functions as an initiator or moderator of mineralization 
/ 
(McCarthy and Frassica 1990). It is not an exclusive bone protein, and is present in platelets 
as well. 
Bone matrix sialoproteins 
They are also present in osteoid and include osteopontin and bone sialoprotein. They 
can bind to cell surfaces and facilitate attachment of the osteoblasts to the bone by a particular 
amino acid sequence. 
Other non-collagenous proteins 
They include proteoglycans such as biglycan and decorin and have a low molecular 
weight. They are also found in other tissues. There are also some phosphoproteins found in 
bone. 
Osteoblast Phenotype 
The synthesis of large quantities of type I collagen, which form the structural 
framework of the mineralized matrix, is characteristic of the osteoblast phenotype. The other 
proteins and glycoproteins known as the non-collagenous proteins such as osteonectin, 
., 
osteocalcin, sialoproteins, phosphoproteins and proteoglycans, are proteins that tend to remain 
bound to hydroxyapatite crystal surfaces in the presence of 4M guanine-HCl and which are 
synthesized_ by osteoblastic cells (Sodek and Berkman 1987). They all are characteristic of 
the osteoblast phenotype although some of them can be synthesized by other cells and be 
present in other connective tissues. Consequently their specificity to bone tissue cannot be 
clearly assessed. Some studies suggest that the extracellular matrix contributes to both the 
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shutdown of proliferation and the development of the osteoblast phenotype (Owen, Aronow et 
al. 1990). 
The osteogenic expression of osteosarcoma cells is not comparable with normal 
human osteoblast cells. Some studies have been made with osteosarcoma cells (G-63, SaOS-
2 and U2-Os ). They looked at the response of some biochemical markers of the osteoblastic 
phenotype to l,25(OH) 2D3. Osteosarcoma cells have the l,25(OH)2D3 receptor, but they did 
not exhibit the typical hormone-dependant stimulation of either alkaline phosphatase activity 
or osteocalcin synthesis and secretion (Mahonen, Pirskanen et al. 1990). Osteosarcoma cells 
are easy to purchase, they make possible standardization of the culture conditions, 
maintenance is simpler than harvesting normal human osteoblast cells, but they do not express 
normal human osteoblast phenotypes. 
Primary cells must adhere to matrix proteins to survive and proliferate. When these 
cells are cultured under conditions that prevent adhesion and spreading, they stop growing 
and lose viability. This is in contrast with transformed cells that may be anchor-dependant, 
enabling tumor cells in vivo to survive and metastasize. It may not always be possible to 
extrapolate results from osteosarcoma cells cultures, because immortalization (unlimited 
lifespan of those cells) can affect cellular behavior (Perez, Spears et al. 2003). 
The history of culturing normal human osteoblast cells to look at their ability to 
produce hydroxyapatite and their expression of biochemical markers was first established by 
Koshihara in 1987 (Koshihara, Kawamura et al. 1987), using periosteum specimens from 
femurs from 20 year-old males to harvest normal human osteoblast-like cells. The results 
showed that the cells responded to various hormones and drugs, such as 1,25(OH)2D3, 
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prostaglandin E2, calcitonin, and both human and bovine 1,34-parathyroid hormones. They 
demonstrated that l,25(OH) 2D3 increased the alkaline phosphatase activity, osteocalcin 
production and the formation of hydroxyapatite. The results indicated that the osteoblastic 
cells described in the study are useful for the study of human bone formation and regulation 
of osteoporosis. 
Effectors of osteoblast activity 
Proliferation and differentiation of osteoblast precursors appears to be controlled by 
circulating molecules, local bone growth factors, and mechanical loading. Although growth 
factors· compose less than 1 % of the non-collagenous matrix proteins, they play criticals roles. 
Some of these mediators of osteoblast differentiation include bone morphogenetic proteins 
(BMPs), transforming growth factor-~, parathyroid hormone, estrogen, and 1,25-
dihydroxyvitamin D3 (Stein, Lian et al. 1996). 
Inorganic matrix 
This represents the mineral phase of bone. It performs two essential functions: it 
serves as an ion . reservoir, and it gives bone most of its stiffness and strength. A very high 
percentage of the body's calcium (99% ), phosphorus (85%) and sodium ( 40-60%) are 
associated with the bone mineral crystal. Bone mineral crystals are not pure hydroxyapatite 
(Ca10[PO4][OH2] 2). They contain both carbonate ions and acid phosphate groups (HPO4-2) 
and they do not contain OH groups. Therefore bone mineral crystals should be classified as 
apatite rather than hydroxyapatite (Buckwalter, Glimcher et al. 1996). The bone mineral 
crystals are relatively small in size compared with the hydroxyapatite crystals formed in 
dental enamel (Robey and Termine 1990). 
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Alkaline phosphatase 
It is not a matrix protein, but is an important synthetic product of osteoblasts. It is the 
most prominent enzyme associated with osteoblastic differentiation. Alkaline phosphatase is 
an ectoenzyme that can hydrolyze monophosphate esters at a pH optimum, has limited 
specificity, and presumably participates in the mineralization process. It hydrolyses p-
nitrophenol phosphate to yield p-nitrophenol and inorganic phosphate. It belongs to a class of 
cell surface proteins that are covalently bound to phosphatidyl inositol phospholipid 
complexes in the plasma membrane. Its active site is accessible from the extracellular fluid. 
To date, the precise role of this enzyme in bone is not known, but alkaline phosphatase 
activity is present when cells become recognized as preosteoblasts and osteoblasts and it is 
absent from the osteocytes. Highest levels of activity are seen in mature, matrix synthesizing 
osteoblasts. In mineralization, the initiation and progression are separate phenomena and 
organic phosphate and alkaline phosphatase play a crucial role in the initiation of 
mineralization, but are not required for the continuation of mineralization of bone nodules 
(Bellows, Aubin et al. 1991 ). It is generally accepted that as the specific activity of the 
alkaline phosphatase in a population of bone cells increases, there is a corresponding shift to a 
more differentiated state, and the level of alkaline phosphatase has routinely been used for in 
vitro experiments as a relative marker of osteoblast differentiation (Aubin, Kursad et al. 
1993). Alkaline phosphatase expression appears in differentiating osteoblastic cells prior to 
expression of the matrix molecule osteocalcin. Alkaline phosphatase has an enhanced 
expression immediately following the proliferative period and the increase in osteocalcin 
expression occurs later, at the onset of mineralization (Owen, Aronow et al. 1990). 
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This enzyme can be demonstrated in the cytoplasm of osteoblasts by special 
histochemical stains. In humans, there are several structurally different isoenzymes of 
alkaline phosphatase encoded by separate genes. The alkaline phosphatase synthesized by 
osteoblasts is similar to the alkaline phosphatase produced by the liver and kidney. The 
common form of alkaline phosphatase is a cell membrane-associated enzyme expressed by 
liver, bone, kidney and placenta from a single gene (Eyre 1997). The four types differ only in 
their post translational carbohydrate modifications (Peel and Eastell 1993). Although needed 
locally for the mineralization process, some osteoblastic alkaline phosphatase escapes into the 
serum (McCarthy and Frassica 1990). 
Biochemical markers of bone formation 
Collagen. Type I collagen is the predominant secretory product of osteoblasts . 
. Therefore, its precursors extension peptides would appear to be good markers of bone 
formation. However, Type I collagen is also the major protein of several tissues. It suffers 
from a lack ofbone specifity (Robey and Termine 1990). 
Osteocalcin. The level of osteocalcin in the serum can be measured by radioimmune 
assays specific to that protein, which use specific monoclonal antibodies to measure intact or 
almost intact molecules that preserve the N-terminal sequence ( e.g. by a 2-site assay format) 
(Eyre 1997). From 10 to 25% of total osteocalcin is not deposited in the bone matrix and 
escapes into the circulation, making possible the · measurement of serum osteocalcin. 
However, under conditions of osteobalst physiologic or pathologic activity, the pool of 
osteocalcin escaping from the osteoblast may change and alter the output (Eyre 1997). 
Osteocalcin is a marker more specific than collagen because it is found only in bone, teeth and 
mineralizing cartilage. There is a general agreement that circulating osteocalcin is positively 
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correlated with parameters of bone turnover, more specifically bone formation (Robey and 
Termine 1990). 
Serum alkaline phosphatase. As described earlier, this enzyme is released into the 
blood stream, and elevated levels correlate with increased osteoblastic (bone-forming) 
activity. It can also be demonstrated in the cytoplasm of osteoblasts by special histochemical 
stains. Earlier studies have demonstrated that alkaline phosphatase can be found in 
preosteoblasts and that its activity increases when there is a shift to a more differentiated state, 
whereas osteocalcin is not expressed in preosteoblasts, but only in osteoblasts (Mulkins, 
Manolagas et al. 1983; Beresford, Gallagher et al. 1986; Kurihara, Ishizuka et al. 1986). The 
level of alkaline phosphatase has been routinely used for in vitro experiments as a relative 
marker for osteoblast differentiation (Owen, Aronow et al. 1990). 
Cell cultures 
Several methods have been used to isolate osteoblasts, to culture them, and to develop 
our knowledge about the limitations of those techniques. 
Enzymatic isolation 
The method utilizes a bacterial collagenase-rich protease mixture to perform a time 
release of cells from the bone surface (Sodek and Berkman 1987). Cells are obtained by 
enzymatic digestion from embryonic calvaria because they are abundant in that tissue. Non-
osteoblastic cells, such as fibroblasts found in the outer layer of the calvaria, are released first 
during the first 10 to 20 minutes of the enzymatic digestion, whereas osteoblasts in the inner 
layer are released later. 
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The disadvantage of this technique include the heterogeneity of the cell population, the 
change in cell phenotype during culture and with subsequent passages, and the inconvenience 
of sacrificing animals each time (Raisz and Rodan 1990). 
Explant procedure 
Bone cells are allowed to grow out from bone explants obtained from adult tissues, 
such as trabecular :fragments obtained as biopsies or at surgery. The cells will retain 
osteoblastic properties on subsequent cultures (Sodek and Berkman 1987). However, there is 
a probable change of phenotype with subculture; so many passages are not indicated. Due to 
the limited amount of material, it may not provide sufficient material for studying basic 
mechanisms and for purifying cell products, but it could be useful in studying cellular and 
molecular defects associated with human diseases (Raisz and Rodan 1990). 
Mechanical isolation 
The isolation technique is based on the ability of osteoblasts to migrate from bone onto 
glass fragments. Frontal and parietal bone from calvariae of mice are dissected and cleaned 
from all the fibrous tissue with the fine forceps and placed in culture with :fragmented glass 
coverslips to allow cells to grow on them. Cell multilayers are obtained, scrapped off, and 
transferred to a tissue culture dish. The same disadvantages apply to this technique as for the 
enzymatic isolation technique. 
Cloning osteoblastic cells 
The cells obtained by cloning are osteosarcoma cell lines. They have the advantage of 
providing large numbers of genotypically homogeneous cells that retain their phenotype over 
multiple passages in culture. However, they are transformed cells and they differ in their 
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growth control features, cytoskeletal organization , oncogene expression, and growth factor 
production (Raisz and Rodan 1990). That is the reason why those cell lines are not used if the 
goals are to reproduce the exact human osteoblast phenotypes. 
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Silicon and osteogenicity 
It is within the last 30 years that silicon has been recognized as participating in the 
normal metabolism of higher animals and as an essential trace element. Prior to that period, 
silicon was classified along with other 20-30 other elements as one of the environmental 
contaminants that occur in highly variable concentration in living tissues, but do not meet the 
criteria for essentiality (Underwood 1971). Since then, it has been proven that silicon is an 
essential metabolite of eukaryotic cells and organisms and is dietary essential (Carlisle 1975). 
Over the years, evidence has accumulated from biological studies that elements other than 
calcium, phosphorus, and magnesium are involved in bone metabolism. 
Carlisle in 1970 (Carlisle 1970) demonstrated that silicon is localized in active growth 
areas in young bones and as the bone becomes more "mature" and mineralized, silicon 
content falls below the detection limit. Is has also been shown that silicon is required for 
growth and skeletal development in the chick (Carlisle 1972), and the rat (Schwarz and Milne 
1972), and for bone, cartilage, and connective tissue formation (Carlisle 1976; Carlisle 1980; 
Carlisle 1980; Carlisle 1981). Those studies confirmed the postulate that silicon is involved 
in early stages of bone formation. 
A relationship between silicon, age, and endocrine balance has been reported. 
Changes in silicon levels that occur in elderly might be explained by their decline in hormonal 
activity (Chamot and Peres 1971; Chamot and Peres 1971; Chamot, Asseko et al. 1977). 
Another study looked at the effect of silicon on endocrine balance. The study was done on 
mature ovariectomized rats and showed that short-term preventive treatment with organic 
silicon silanol reduced the osteoclast surface, increased endosteal bone formation and partially 
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prevented the trabecular bone volume, suggesting that an organic form of silicon may help in 
the prevention of osteopenia related to estrogen deficiency (Hott, de Pollak et al. 1993). 
After it was established that silicon is an essential element for bone growth and 
development, some studies were designed in an attempt to identify the bonding site of silicon. 
Silicon was found to be a constituent of certain glycosaminoglycans and polyuronides, where 
it occurs firmly bound to the polysaccharide matrix. Silicon may function as a biological 
cross-linking agent and contribute to the architecture and resilience of connective tissue 
(Schwarz 1973). Carlisle confirmed th_at finding in 1976 (Carlisle 1976) by demonstrating 
that silicon deficiency affects the glycosaminoglycan content of connective tissue. Silicon 
was also found in mitichondria as Si-containing mitochondrial granules (Mehard and Volcani 
1976). Those granules could be involved in the storage of silicon, accumulation of excess of 
silicon or accumulation of silicon needed for mineralization. 
Some studies looked at the in vivo effect of silicon on calcification (Carlisle 1970; 
Carlisle 1_978). They showed that a high silicon diet leads to bone mineralization occurring 
much more rapidly. In 1980 (Carlisle 1980), Carlisle also demonstrated that skull 
abnormalities associated with reduced collagen content have been produced in silicon-
deficient chicks. The skull appeared to be shorter and narrower. Carlisle (Carlisle 1981) also 
demonstrated that the defects of development of bone matrix in silicon deficient chicks are 
independent of vitamin D, supporting the postulate that silicon is involved in early stage of 
bone formation. 
Earlier, Carlisle and Alpenfels (Carlisle and Alpenfels 1978) looked at bone growth in 
culture. Paired frontal bones from 14-day-old chick embryos were grown in low-silicon and 
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silicon-supplemented media for 12 days. The results demonstrated that bone growth and 
collagen synthesis are dependant upon the presence of silicon. 
Some other studies looked at the effect of silicon on cell proliferation and 
differentiation. Keeting et al. (Keeting, Oursler et al. 1992) studied the effect of a silicon-
containing compound (Zeolite A) on normal human osteoblast-like cells for a 48h period. 
The zeolite A induced a dose-dependant increase in DNA synthesis, an increase in alkaline 
phosphatase activity, osteocalcin release and the secretion of latent TGF-~. No significant 
effect was found regarding collagen production. They concluded that ZA induces the 
proliferation apd differentiation of cells of the osteoblast lineage. Therefore silicon ions 
released in physiologic solution may play a role in the regulation of osteogenic behavior. 
Another way to have silicon ions released in a physiologic medium is to use bioglass 
materials. Some studies tested those materials in vivo by inserting them in a bony defect to 
observe bone regeneration over time. Other studies looked at the effect in vitro of bioglasses 
by culturing cells on their surfaces. Chou et al. (Chou, Al-Bazie et al. 1998) studied the 
mechanisms underlying the osteogenic effects of bioglass materials and hydroxyapatite by 
implanting them endosteally in bilateral proximal tibial condyles of rabbits. The results 
showed that at two weeks, higher silicon containing material generated the greatest amount of 
woven bone and cartilage which was replaced by dense compact bone at 8 weeks. A quick 
release of high levels of silicon had a significant osteogenic effect, stimulating osteocalcin 
synthesis at the early stage of implantation and producing a greater amount of new bone. 
All those studies lead to the proposition of silicon as a key element in stimulating 
osteogenesis and in influencing osteogenic activity. As mentioned earlier, silicon is also 
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found in bioglass materials, among other elements. Here are some studies and roles of the 
bioglass materials, also named bioactive glasses. 
Bioactive Glasses 
Bioactive glasses are silica-based, surface-active bone substitutes that have shown 
good biocompatibility both in bone and soft tissue and can be used in oral and maxillofacial 
bone augmentation. Bone repair may be one of the first major applications of tissue 
engineering, which consists of the use of materials to promote new tissue formation. It 
involves interaction of cells with the material. 
Over the last 30 years, we have seen the development of the first, second and third 
generation of biomaterials designed for tissue regeneration. The basic structure of bioactive 
glasses is Na20-Ca0-P 20 5-Si0 2. This structure forms a strong, adhesive bond to bone. These 
materials become "bioactive" due to a controlled reaction with the physiologic environment. 
It generates a hydroxycarbonate (HCA) layer that is equivalent chemically and structurally to 
the mineral of bone, and bonds directly to host tissues by interdigitating this layer with 
cement lii;ie matrices or collagen fibers produced by bone cells (Hench and Wilson 1984). 
Ohgushi et al. in 1996 (Ohgushi, Dohi et al. 1996) investigated the significance of apatite-
wollastonite-containing glass ceramic surfaces, the biological apatite layer found on these 
surfaces and its effects on osteogenic differentiation of cultured marrow stromal cells. They 
also agre,ed that the glass ceramic surface promotes osteoblastic differentiation and that it is 
further enhanced by the formation of a biological apatite layer. 
The tissue response to the second generation biomaterials like hydroxyapatite is 
termed osteoconduction, a process in which bone grows along the coating and forms a 
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mechanically strong interface. Within that generation came the new concept of combining 
bioactivity with t~e physical properties of polymers in the form of bioactive composites. 
Another advance was the development of resorbable biomaterials that exhibited controlled 
chemical breakdown and resorption when implanted in the body. The foreign material is 
ultimately replaced by regenerating tissues. 
For the third generation ofbiomaterials, bioactive materials are being made resorbable 
and resorbable polymers are being made bioactive (Hench and Polak 2002). They are being 
designed to activate genes that stimulate regeneration of living tissues. There are two 
concepts for this third generation: tissue engineering where progenitor cells are seeded onto 
biologically active resorbable scaffolds, and in situ tissue regeneration which involves the use 
ofbiomaterials to stimulate local tissue repair (Hench, Xynos et al. 2004). 
Bioactive materials must possess controlled release kinetics that synchronize with the 
sequence of cellular changes occurring in wound repair. Bioactive glasses are divided into 
two classes. Class-A glass has both osteoconduction and osteoproduction activity. Wilson 
(Wilson and Low 1992) defmes osteoproduction as "the process whereby a bioactive surface 
is colonized by osteogenic stem cells free in the defect environment as a result of surgical 
intervention". Class-A glasses have a rapid release of soluble ions, causing rapid reactions on 
the surface that go to completion within 2 to 24h. Class-B glass has only osteoconduction 
present i.e. "bone migration along an interface and due to slower surface reactions, minimal 
ionic release and only extracellular responses occur at the interface" (Hench, Xynos et al. 
2004). 
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The effect of rapid release of soluble ions from class-A bioactive glasses is the 
formation of high surface area hydrated silica and an HCA bi-layer on the glass surface. 
Attachment, differentiation and proliferation of osteoblasts rapidly occur on the surface and 
mineralization of the matrix follows soon thereafter. Mature osteocytes are the final product 
by 6-12 days both in vitro and in vivo (Xynos, Hukkanen et al. 2000). The HCA layer 
provides many binding sites for the cytokines of osteoprogenitor cells. Xynos et al. also 
showed that osteoblasts grown for only 48h on bioactive glass had more anchoring sites than 
the cells grown on the inert plastic controls. When osteoblasts are grown on bioactives 
glasses~ more cells undergo apoptosis, but the cells that are left are capable of differentiation, 
proliferation and matrix production. Fewer cells undergo apoptosis when exposed to bioinert 
substrate, but they are seldom capable of differentiating and forming bone matrix. Those 
findings demonstrate that bioactive glasses have an important effect on the cell cycle. The 
same authors, in 2000 and 2001 (Xynos, Edgar et al. 2000; Xynos, Edgar et al. 2001) have 
also shown that the mechanism for in situ regeneration involves upregulation of several 
families of genes that control the osteoblast cell cycle. The cell cycle is under genetic control. 
· El-Ghannan et al. (El-Ghannam, Ducheyne et al. 1997) also looked at the importance 
of the HCA layer when bioactive glasses were previously treated with a fluid similar to 
interstitial fluids (TE) before cells were seeded on its surface. When the glass surfaces are 
modified by treatment with TE, there is adsorption of serum proteins onto this carbonated 
hydroxyapatite layer. It enhances bone cell adhesion, proliferation and function when 
compared to groups where the cells are seeded on an amorphous calcium ph~sphate (no 
u;eatment). This enhancement of osteoblast phenotypic expression might be due to the 
selective adsorption of fibronectin on the carbonated hydroxyapatite layer. Matsuoka et al. 
(Matsuoka, Akiyama et al. 1999) also looked at the effect of conditioning highly bioactive 
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apatite with simulated body fluid (SBF) on the stimulation of bone formation. W ollastonite-
containing glass-ceramic (AW) releases an appreciable amount of Ca and Si ions. AW disks 
significantly increased [Ca2+]e in the culture medium up to 12 days, the peak being at 48h. 
This release of [Ca2-r-]e was significantly suppressed by the apatite layer forming following 
conditioning, whereas the apatite layer did not inhibit the release of Si significantly. 
Exposure to high Si increased alkaline phosphatase activity in cells in a dose-dependant 
manner and both Ca2+ and Si ion release promoted the differentiation of osteogenic cells. 
In summary, many authors have demonstrated that the formation of an HCA layer by 
bioactive glasses in contact with body fluids is a key element in the stimulation of bone 
formation. Improved cell adhesion to bioactive glasses has been identified as one of the 
events involved in the bone bioactivity cascade and is in part explained by enhanced cell 
receptor-fibronectin interactions, suggesting substrate dependant conformational changes in 
the adsorbed fibronectin (Garcia, Ducheyne et al. 1998). However, fibronectin is not specific 
for signaling cells toward osteogenic differentiation. Gao T et al. in 2001 (Gao, Aro et al. 
2001) looked at the expression of some signaling proteins and molecules by cells cultured on 
two bioactive glasses with different Si content. Their findings suggest that not only chemical 
reactions are involved on the bioactive glass surface, but it also involves biological responses 
seen by the enhanced BMP-2 expression in osteoblasts cultured on the bioactive glass surface. 
The Si component of the bioactive glass is suggested to selectively activate some osteogenic 
genes of osteoblasts. 
Because of their potential to induce differentiation of osteoblast-like cells and inhibit 
osteoclast-like cells formation with an activity comparable to TGF-~, bioactive glass 
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substrates have good potential implications in tissue engineering and could be used as 
scaffolds for in vitro production of bioengineering bone (Bosetti and Cannas 2005). 
MTA and Endodontics 
Roots canal treatments can be very challenging. Even with the right diagnosis and the 
appropriate treatment, it can lead to failures. In the Washington study (Ingle 1985; Stabholz, 
Friedma!l et al. 1994), the causes of failures were classified into three main groups. Apical 
percolation as a result of incomplete obturation and unfilled canals accounted for 63.5% of 
failures. Operative errors, such as root perforation, gross overfilling, and broken instrument, 
made up 14.5%. Errors in case selection and treatment of cases with root resorption or 
coexisting periodontal pathology constituted 22%. The basic concepts of endodontics have 
stayed unchanged: good cleaning and shaping of all the canals, proper obturation of those 
~ canals and good coronal sealing after endodontic treatment. However, when faced with an 
endodontic failure, the clinician must try to establish the possible causes of the problem, so 
that it may be remedied successfully. 
The preferred treatment of failing endodontic cases is non-surgical retreatment. In 
most cases, retreatment results in successful outcomes. However, according to some studies 
(Molven, Halse et al. 1988; Sjogren, Hagglund et al. 1990; Sundqvist, Figdor et al. 1998), 
between 25% and 3 8% of the retreated cases still fail. Those failures can be attributed to the 
complexity of the root canal system leading to improper cleaning and shaping using present 
techniques and instruments, or the presence of physical barriers, or the presence of resistant 
bacteria strains. Therefore, surgical endodontic therapy becomes the first alternative. Some 
studies report an overall success rate for periradicular surgery of 75% (Testori, Capelli et al. 
1999) which is increased to 85% with the use of ultrasonic technique and Super-EBA 
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compared to amalgam and rotary instruments. The use of a surgical operating microscope and 
Super-EBA lead to a success rate of 96.8% after a one year recall (Rubinstein and Kim 2002). 
The surgical endodontic procedure involves exposing the apex, resecting the root-end, 
and inserting a root-end filling material. The purpose of placing a root-end filling material is 
to create a hermetic seal that prevents the egress of root canal contaminants or irritants into 
the periradicular tissues and that prevents the leakage of those irritants that may cause some 
inflammation of the periradicular tissues. 
Endodontically treated teeth that required surgical treatment often have chronic 
periradicular periodontitis associated with them. Those lesions are formed in response to the 
presence of bacteria and their by-products or by some foreign materials present in the 
periradicular area like gutta-percha, amalgam, endodontic sealers or broken instruments. Its 
then leads to the creation a low grade chronic inflammation or infection that can become acute 
when the host defense system is compromised or when the virulence of the pathogens 
increases. The soft tissue lesion that is then present in the created bony defect continues to 
exparid and to increase as long as the irritants keep emanating from the root canal system. 
This bony defect around the apex of the tooth is initially created by the inflammatory process 
with the release of cytokines and other inflammatory mediators that are responsible for the 
activation of osteoclasts, which are responsible of bone resorption. 
Preparing for endodontic microsurgery encompasses strong magnification, high 
illumination, and precise instrumentation. Good local anesthesia and hemostasis are a 
prerequisite for microsurgery. The soft tissue management consists of a sulcular full-
thickness flap or a mucogingival flap, incision, elevation and retraction. Osteotomy (i.e. the 
30 
removal of the facial cortical plate to expose the root-end) must be performed over the apices 
to get good access and visualization. Periradicular curettage is done to expose the root tip. 
Apical resection consisting of the removal of 3mm of the root tip perpendicular to the long 
axis of the root is then accomplished. After microinspection of the resected root surface, an 
apical preparation (class I cavity) is made using ultrasonics to a depth of 3mm. The 
preparation is dried and a root-end filling material is used to seal the apical region (Kim 
2000). 
A significant number of researchers and clinical studies have attempted to identify the 
ideal root-end filling material. According to Gartner and Dom (Gartner and Dom 1992), an 
ideal root-end filling material should have these properties: 
" 1. Seal the apical portion of the root canal system in three dimensions; 
2. Be well tolerated by periradicular tissues with no inflammatory reactions 
3. Be non-toxic both locally and systemically; 
4. Not promote, and preferably inhibit, the growth of pathogenic organisms; 
5. Stimulate the regeneration of normal periradicular tissues; 
6. Not be affected by moisture in either the set or unset state; 
7. Not be absorbable by the body within the confines of the tooth, but excess 
should be absorbable; 
8. Be dimensionally stable and should not expand, contract, or flow in any 
direction when set; 
9. Not corrode or be electrochemically active; 
10. Not stain the tooth or the periradicular tissues; 
11. Be easy to mix and insert; 
12. Be easily distinguishable on radiographs; and 
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13. Adhere or bond to the tooth without the need of undercuts." 
· In addition, regeneration of cementum, periodontal ligament and alveolar bone across 
the resected root-end surface and across the root-end filling material is another ideal goal to 
achieve. This consists of complete regeneration, which is defined as the replacement of tissue 
components in their appropriate location, amounts, and relationship to each other. Amalgam, 
composites, resins zinc oxide eugenol cements (IRM and Super-EBA), glass ionomer cement, 
polycarboxylate cement, cavit, gutta percha and other materials such as gold foil, Teflon, 
poly:-Hema and Hydro, zinc phosphate cement and cyanoacrylate cement are among the 
materials that have been discussed or suggested as root-end filling materials in the past 
(Friedman 1991). These materials are usually placed in direct contact with the periodontium 
for a prolonged period of time; therefore their biocompatibility is of primary importance. 
Amalgam has been one of the most widely used materials. Since it has been used for 
decades, it has been established that it was well tolerated by oral tissues. It is easy to 
manipulate, radiopaque, cheap, has a good setting time and it is not too technique sensitive. 
However, some potential disadvantages are release of mercury and other ions, corrosion and 
electrolysis, amalgam tattoo (argyrosis), delayed expansion, and marginal leakage. It is 
difficult to place without scatter, excess material is non absorbable and spontaneous expulsion 
of the material due to apical remodeling, improper placement or delayed expansion is possible 
(Gartner and Dom 1992)~ 
When compared to amalgam, Super-EBA and IRM have an increased success rate and 
are a good alternative to amalgam. Super-EBA is ·reinforced with alumina and the liquid 
contains only 37.5% eugenol compared to 99% in IRM. Super-EBA has shown to provide a 
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superior seal to IRM and amalgam (Fischer, Arens et al. 1998; Fogel and Peikoff2001; Tang, 
Torabinejad et al. 2002). It adheres well to dentinal walls. In addition, EBA cements are less 
absorbable by the body because of reinforcement with either aluminum oxide or silicon oxide 
and collagen fibers growing over its surface. However, some disadvantages are tissue 
irritation from eugenol release, moisture sensitivity, partial solubility in oral fluids and 
difficulty in clinical handling of the material (Torabinejad, Watson et al. 1993). 
Many root-end filling materials have been tested over the years in an attempt to find 
the ideal material. In 1993, a new material, mineral trioxide aggregate (MTA), was 
introduced as a very promising material. It was developed by researchers at Loma Linda 
University School of Dentistry and has been widely investigated for its variety of potential 
applications. Studies have demonstrated that MTA is a very promising material because of its 
.. ability to promote regeneration of periradicular tissues, such as periodontal ligament, bone, 
and cementum when MTA was used in endodontic procedures (Schwartz, Mauger et al. 1999; 
Torabinejad and Chivian 1999; Giuliani, Baccetti et al. 2002). There are also reports of its 
superior biocompatibility and low cytotoxicity with periodontal tissues (Torabinejad, Hong et 
al. 1995; Torabinejad, Pitt Ford et al. 1997), the possibility to use it in the presence of 
moisture, good sealing ability (Torabinejad, Watson et al. 1993; Torabinejad, Higa et al. 
1994; Torabinejad, Rastegar et al. 1995), and appropriate physical properties for use as a root-
end filling material (Torabinejad, Hong et al. 1995). MTA has some advantages over existing 
root-end filling materials. It is easy to mix and place into the cavity preparation with a small 
amalgam carrier, it is not essential to use it in a dry field and excess is easy to remove. A 
djsadvantage ofMTA is its long setting time (Torabinejad, Watson et al. 1993). 
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These encouraging outcomes from in vivo and in vitro studies have prompted many 
clinicians to consider the use of MTA as a root-end filling material and also as a material 
suitable for repairing perforations and performing apexifications. MT A may be the ideal 
material because it is the only material that consistently allows for the regeneration of the 
periodontal ligament, the apposition of cementum-like material and formation of bone 
(Schwartz, Mauger et al. 1999). 
MTA 
MT A is a fine powder primarily composed of tricalcium silicate, tricalcium aluminate, 
tricalcium oxide, and silicate oxide. Bismuth oxide powder is added to make the aggregate 
radiopaque. In addition, there are small amounts of a few other mineral oxides that are 
responsible for the chemical and physical properties of this aggregate. Hydration of MTA 
~ powder forms a colloidal gel that solidifies in approximately 3 hours (Torabinejad, Hong et al. 
1995). Therefore, when used as a perforation repair material, although the periradicular 
tissues provide some moisture from the external surface of the material, to assure proper 
setting, moisture must also be provided from the internal aspect of the tooth using a cotton 
pellet. The material is fully set in 24h and has higher resistance to displacement after 72 
hours (Sluyk, Moon et al. 1998). Its compressive strength significantly increased at 21 days 
compared to 24h (Torabinejad, Hong et al. 1995). The characteristics of the aggregate depend 
on the size of the particles, powder-to-water ratio, temperature, presence of water and 
entrapped air. There is a grey and a white MTA formula. The grey MTA has been associated 
with occasional staining of the teeth when used in pulpotomy and pulp capping procedures. 
Therefore, a white MT A material has been developed. In the white MTA formula, there is no 
tetracalcium aluminoferrite, but both the grey and the white MTA formulae contain 75% 
Portland cement, 20% bismuth oxide and 5 % gypsum by weight (Dentsply, Tulsa Dental). 
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According to Torabinejad et al. (Torabinejad, Hong et al. 1995), MTA has a pH of 10.2 
initially, which rises to 12.5 3 hours after mixing when placed in proper setting conditions. 
This is similar to calcium hydroxide material. 
Clinical Uses of MT A 
MTA has several clinical applications such as application as an apical barrier 
(apexification) in teeth with immature apices (Shabahang, Torabinejad et al. 1999; Shabahang 
and Torabinejad 2000) repair of root perforations (Lee, Monsef et al. 1993), root-end filling 
material (Torabinejad, Watson et al. 1993; Torabinejad, Hong et al. 1995; Bates, Carnes et al. 
1996), direct pulp capping (Ford, Torabinejad et al. 1996) and pulpotomy (Eidelman, Holan et 
al. 2001). 
Sealing Ability 
Micro leakage is considered an important factor in success or failure of root-end filling 
material and perforation repairs. To test the sealing ability of MTA, several different 
techniques have been used including dyes, bacteria, fluid transport method, capillary flow 
porometry and fluorescent dyes. The bacteria leakage method is sometimes preferred over the 
other methods because it reproduces more accurately the clinical situation. However, results 
of some other methods will also be discussed. In a fluorescent dye leakage study, Torabinejad 
M et al. in 1993 (Torabinejad, Watson et al. 1993) demonstrated that MTA leaked 
significantly less than amalgam and Super-EBA. Using methylene blue as a dye, it was also 
demonstrated that when exposed to blood contamination, there was no significant difference 
~ terms of leakage and MTA still performed better than Super-EBA, IRM and amalgam 
(Torabinejad, Higa et al. 1994). Most of these studies looked at the leakage after 24h or a few 
days, but Wu et al. (Wu, Kontakiotis et al. 1998) did a leakage study over a 12 months period 
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and showed that MT A and glass ionomer cements leaked less than conventional amalgam and 
Super-EBA, of which amalgam leaked more. The sealing ability of set MT A when resected is 
not affected (Andelin, Browning et al. 2002). Another in vitro study using the bacteria 
leakage model showed that, when inoculated with Prevotella nigrescens bacteria, the three 
root-end filling materials (Geristore, Super-EBA and MTA) were not significantly different 
against penetration of the bacteria after 4 7 days (Scheerer, Steiman et al. 2001 ). Fisher et al. 
(Fischer, Arens et al. 1998) looked at the time needed for Serratia marcencens to penetrate a 
3mm thickness of zinc-free amalgam, IRM, Super-EBA and MTA. MTA did not begin until 
49 days which was later than the other materials and 4/10 MTA samples had not exhibited 
any leakage at 120 days. Endotoxin leakage, a component of the cell wall of Gram negative 
bacteria which has pro-inflammatory properties, could also play a role in the pathogenesis of 
periradicular lesions. Tang HM et al. (Tang, Torabinejad et al. 2002) studied the presence of 
.,. endotoxins when MTA, amalgam, IRM and Super-EBA were used as root-end filling 
materials. MT A provided the most , effective seal against endotoxin leakage. The only 
situation where MTA wasn't proven to provide a better seal was when it was used as a root 
canal filling material. The apical seal produced by traditional gutta percha techniques was 
superior to that produced by MTA (Vizgirda, Liewehr et al. 2004). This could be attributed to 
improper setting of the MT A caused by a lack of moisture in the mid-root section. 
The sealing ability of MT A was also studied when the material was used in furcal 
perforation repairs. Long-term success of perforation repair has been shown to depend upon 
the duration of the septic exposure, the size and location of the perforation, the degree of 
insolubility of the material and the ability to seal the defect. Grey and white MT A showed 
similar leakage when exposed to Fusobacterium nucleatum (Ferris and Baumgartner 2004). 
When exposed to a tracer dye, perforations repaired with MT A leaked less than the ones 
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repaired with Vitrebond (Daoudi and Saunders 2002). MT A and Super-EBA sealed the 
perforations very well over a one month period (Weldon, Pashley et al. 2002). MT A 
demonstrated a good sealing ability when used either as a root-end filling material or as a 
perforation repair material. 
Cellular Response to MT A 
In vitro studies 
As an important factor of biocompatibility, in vitro cytotoxic screening is determined 
by •cell culture of different type using primary or transformed cells. Cytotoxicity studies can 
be done with the cells in direct contact with the test materials or with the materials in 
suspension above the cell cultures like the insert wells method. Torabinejad et al. 
(Torabinejad, Hong et al. 1995) tested the cytotoxicity of MTA with two different methods. 
~ The agar overlay method, which consists of placing samples of the materials onto the agar 
overlay containing the cells, showed that the zones of lysis around freshly mixed amalgam 
and Super-EBA were significantly larger than those observed among their set counterparts. 
No significant statistical difference was found between the zones of lysis around freshly 
mixed and set MT A. With this technique, amalgam was less cytotoxic than MT A and they 
were both less cytotoxic than Super-EBA and IRM. The second method used in this study 
was the radiochromium release method, which consists of labeling the cells before culturing 
them onto the tests materials and then measuring the radiochromium release in the culture 
medium by non-viable cells. All freshly mixed root-end filling materials were cytotoxic, the 
least being MT A followed by amalgam, Super-EBA and IRM. This order stayed unchanged 
w~en 24h set materials were tested. Those results showed that MT A has minimal cytotoxicity 
when freshly mixed or in its set state. Using inserts culture and L-929 fibroblasts, Osorio RM 
et al. (Osorio, Hefti et al. 1998) showed that MTA was not cytotoxic for the cells used in the 
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study. The study by Keiser et al. (Keiser, Johnson et al. 2000) was in agreement with two 
.previous studies by concluding that MT A was proven to be less toxic to human PDL cells 
than Super-EBA at all concentrations in both the freshly mixed and 24h set states. When 
human osteoblasts were grown in the presence of MTA, cells adhered to the MTA and 
produced more cytokines than the cells grown in the absence of MTA. Osteocalcin and 
alkaline phosphatase were also more elevated (Koh, Torabinejad et al. 1997). Some authors 
have attributed , the cell response to MT A to its release of calcium ions in the culture medium. 
So, the response of human osteoblasts in vitro was favorable in the presence of MT A. 
It seems that MTA offers a biologically active substrate for bone cells and stimulates IL 
production. Cells grown in contact with MT A have a healthy morphology. They spread and 
adhere to the material (Koh, McDonald et al. 1998; Zhu, Haglund et al. 2000). 
Since two different versions of the MT A are now available on the market, some 
studies were conducted to compare the two materials. Peres et al. (Perez, Spears et al. 2003) 
showed in their study that primary osteoblasts harvested from foetal rat calvaria had initially 
bound to white MT A and grey MT A, but they did not survive on the white MTA surface by 
the end of the 13 days experiment whilst MG-63 osteosarcoma cells did. This could be 
explained by the different surface topographies of the two materials when hardened even if 
the manufacturer says that there is very little difference in the particle size of the grey and 
white MT A. The major difference resides in the reduction in the iron component of the white 
MTA which could contribute to the osteoblasts not remaining attached. According to this 
study, primary osteoblasts would be more appropriate than MG-63 osteosareoma cells for 
testing endodontic materials in cell culture because they are more sensitive and able to 
differentiate and to mineralize. 
38 
In vivo studies 
The periradicular response to MTA in vivo is also an important factor to consider. 
When compared to amalgam as a root-end filling material in monkeys, MT A showed no 
periradicular inflammation adjacent to five of six root ends filled with MTA and the teeth had 
a complete layer of cementum over the filling. In contrast, amalgam showed periradicular 
inflammation and had no cementum forming over the filling material (Torabinejad, Pitt Ford 
et al. 1997). This is a really important finding, because it means the complete regeneration of 
the periodontal apparatus which wasn't found with other root-end filling materials. Similar 
results (no inflammation and cementum formation) were seen when MTA was used in lateral 
perforation repairs in mongrel dogs (Holland, Filho et al. 2001 ). Also, when used in furcation 
perforations, MT A showed less inflammation than Super-EBA. In addition, new cementum 
was formed in the perforation area (Yildirim, Gencoglu et al. 2005). The new cementum 
formation over the MT A seems to be a consistent finding in all the studies. According to 
Torabinejad, the formation of cementum against MTA may be due to its sealing ability, 
biocompatibility or alkaline pH on setting. When implanted in the mandibles and tibias of 
guinea pigs and compared to amalgam, Super-EBA and IRM, MTA had the most favorable 
response. Specimens were free of inflammation and were often observed to have direct bone 
apposition (Torabinejad, Ford et al. 1998). When MTA was used as a root-end filling 
material in dogs, Economides et al. (Economides, Pantelidou et al. 2003) observed that the 
healing process around the MT A is characterized initially by fibrous connective tissue 
formation and secondarily by hard tissue repair. Y altirik M et al. in 2004 (Y altirik, Ozbas et 
al. 2004) had similar findings when they implanted MTA into the dorsal skin of Wistar albino 
rats. They noted the presence of dystrophic calcification in conn~ctive tissue adjacent to 
MT A, suggesting hard tissue induction by this material. MT A is not just an inert material. 
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Rather, it may actively promote hard tissue formation. All those studies show that the tissue 
response to MTA is very favorable whether it is used in perforation repairs or as a root-end 
filling material. 
Vital Pulp Therapy 
Direct pulp capping may be a necessary procedure in a situation of incomplete root 
formation and immature apices. To allow the complete formation of the root, healing of the 
pulp is important. This healing is related in part to the capacity of the material to prevent 
bacterial leakage. When used as a pulp capping material in mechanically exposed pulps in 
monkeys, MTA stimulated dentin bridge formatjon adjacent to the dental pulp (Ford, 
Torabinejad et al. 1996). Calcium hydroxide is the most widely used material for direct pulp 
capping. Faraco IM et al. (Faraco and Holland 2001) showed that MT A, when compared to 
calcium hydroxide as a pulp capping material in dogs, exhibited better results than the 
calcium hydroxide cement. They observed complete tubular dentin bridge formation and no 
inflammation of the pulps capped with MT A. MT A offers a biological substrate for pulpal 
cells able to regulate dentinogenic events. Tziafas et al. in 2002 (Tziafas, Pantelidou et al. 
2002) studied the pulp cell responses and the dentinogenic effect of MTA in short term 
healing intervals. The initial effect of MTA is the formation of a homogenous zone of 
crystalline structures along the pulp-MTA interface. MTA induces cytological and functional 
changes in the pulpal cells when in close proximity with the crystals. Those changes result in 
the formation of fibro-dentin and reparative dentin at the surface of the mechanically exposed 
dental pulp. MTA is able to stimulate reparative dentin formation and this regulatory effect of 
MT A might be related to its ability to induce cytokines production. 
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Apical MT A plug and Apexification 
When teeth with incomplete root formation suffer pulp necrosis, root development 
ceases, leaving the root with a large canal, thin and fragile walls and an open apex. To allow 
the condensation of a filling material, an apical stop must be created. Calcium hydroxide 
pastes were the material of choice to induce a calcified barrier, but they were associated with 
an increased possibility of root fracture after a prolonged period of use (Andreasen, Farik et 
al. 2002) and the duration of the treatment and compliance of the patient were important 
disadvantages. Shabahang et al. (Shabahang, Torabinejad et al. 1999) showed that MTA 
induced apical hard tissue formation more often than calcium hydroxide and was associated 
with less inflammation. They observed an apical closure with a calcified barrier in 93% of the 
roots treated with MTA after using calcium hydroxide paste for one week. Felippe WT et al. 
in 2006 (Felippe , Felippe et al. 2006) reported that MTA favored apexification and periapical 
healing of infected dogs' teeth, regardless of the previous application of calcium hydroxide 
paste. So application of MTA in teeth with open apices results in predictable apical closure 
and reduction of the treatment time. 
Antibacterial and Antifungal Properties 
MT A has some antibacterial effect on some of the tested facultative bacteria and no 
effect on strict anaerobic bacteria (Torabinejad, Hong et al. 1995). The antibacterial effect 
could be related to its high pH or release of diffusible substances into the growth medium. 
MT A is also effective in killing Candida Albicans after one day of contact with the fungi 
when tested with freshly mixed MT A and after 3 days when 24h-set MT A was in contact with 
the fungi (Al-Nazhan and Al-Judai 2003). 
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OBJECTIVES OF THIS STUDY 
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Objectives of the study 
The (?bjective of this study was to evaluate the behaviour of normal human osteoblast 
cells in the presence of MTA (white form) and in the presence of two modified mineral 
trioxide aggregates. An amount of SiO2 equal to 30% of the total weight of the MTA powder 
was added to the first modified-MTA (MTA+Si). For the second modification, an amount of 
BIB (Bioactive Inorganic Element) equal to 30% of the total weight of the MTA powder was 
added. Adding 30% BIB to the MTA corresponds to an addition 6% Si and 4.5% Ca. Based 
on previous findings in literature, we hypothesize that the osteogenic behaviour of human 
osteoblast cells will increase with an increase in silicon and/or calcium concentration in 
mineral trioxide aggregate. 
The experiments were designed to achieve the following objectives: 
1. The isolation and growth of osteoblast-like cells; 
2. The characterization of human osteoblast cell culture; 
3. The examination of the effects of MT A, silicon-modified MT A (MT A +Si) and 
BIB-modified MTA (MTA+BIB) on media pH; 
4. The examination of the effects of MTA, silicon-modified MTA (MTA+Si) and 
BIB-modified MT A (MT A +BIB) on cell attachment efficiency and proliferation 
rate; 
5. · The examination of the effects of MTA, silicon-modified MTA (MTA+Si) and 
BIB-modified MT A (MTA +BIB) on alkaline phosphatase activity; 
6. The examination of the effects of MTA, silicon-modified MT A (MT A +Si) and 
BIB-modified MTA (MTA+BIB) on osteocalcin expression. 
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MATERIALS AND METHODS 
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1. Material 
Material Manufacturer 
1,25 Dihydroxycalciferol Vit. D3 Sigma-Aldrich 
Alkaline Buffer Sigma-Aldrich 
Lot 
number 
D1530-
10µg 
A9226 
Location 
St-Louis , MO 
St-Louis , MO 
Charcoal treated FBS Cocalico Biological CBX 1730 Reamstown , 
Crystal Violet (ACS Reagent Dye Sigma-Aldrich 
content 95%), (N-
hexamethylpararosaniline) 
Dulbecco ' s Modified Eagle Medium GIB CO™ 
(DMEM) Invitrogen 
Corporation 
PA 
229288- St-Louis, MO 
100G 
11965-084 Carlsbad , CA 
Ethyl alcohol USP Absolute-200 Proof Aaper Alcohol and 98L09QA 
Chemical Co. 
Shelbyville , 
KY 
F-12 Nutrient Mixture w/Glut (Ham) 
Fetal Bovine Serum (FBS) 
Formalin solution 10% 
GIBCO™ 
Invitrogen 
Corporation 
GIBCO™ 
Invitrogen 
Corporation 
11765-047 Carlsbad , CA 
16000-069 Carlsbad , CA 
Sigma Diagnostics 018H3278 St-Louis, MO 
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Fungizone Amphotericin B GIBCO™ 15290-018 Carlsbad, CA 
Invitrogen 
Corporation 
L-Ascorbic acid Sigma-Aldrich 115H02865 St-Louis, MO 
Menadione (Vitamin K3; 2-methyl-1-4- Sigma-Aldrich 18H0300 St-Louis, MO 
naphoquinone) 
Mineral Trioxide Aggregate (MTA) Dentsply 03081235 Tulsa, OK 
Penicillin-Streptomycin GIBCO™ 15140-122 Carlsbad, CA 
Invitrogen 
Corporation 
p-nitrophenyl phosphate disodium salt Sigma-Aldrich P5994 St-Louis, MO 
hexahydrate (phosphatase substrate) 
Potassium Chloride (KCl) Fisher 942637 Fair Lawn, NJ 
Potassium Phosphate monobasic Fisher 004920 Fair Lawn, NJ 
(KH2PO4) 
Osteocalcin IRMA Kit DiaSorin 32300D Stillwater, MN 
Silicon Dioxide (SiO 2) US Silica 15033100 Berkeley 
Springs, WV 
Sodium Chloride (NaCl) Fisher 942655 Fair Lawn, NJ 
Sodium Phosphate, dibasic, anhydrous Fisher Biotech 975648 Fair Lawn, NJ 
(Na2HPO4) 
Triton X-100 Sigma-Aldrich 34H260015 St-Louis, MO 
Trypsin 0.25% GIBCO™ 15050-057 Carlsbad, CA 
Invitrogen 
Corporation 
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2. Equipment 
Item Manufacturer Model Location Description 
No. 
Gram-AITC E. Mettler 1-910 Switzerland/Heights, Balance 
Balance Zurich/Fisher NJ 
Scientific 
Metler PM 480 Delta Range® PM480 Heights, NJ Balance 
CentricTM Fisher 225 Heights, NJ Centrifuge 
Centrifuge Scientific 
EASY Pure RF Barnstead D7031 Dubuque, IA Deionizer 
Compact 
Ultrapure 
Water System 
Spectral Liquid Wallac Inc. All 1219 Gaithersburg, MD Gamma Counter 
Scintillation 
Counters 
PRECISION Precision 5EM Winchester, VA Incubator 
Economy Scientific 
Incubator 
Water-Jacketed Forma 3158 Marietta, OH Incubator 
Incubator Scientific Inc. 
DAS Leitz DMIL 090- W etzlar, Germany Microscope 
Mikroskop 131.002 
Accumet Metro Fisher 01375 USA pH meter 
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(Acco-pHast™ Scientific (69490) 
Combination 
Electrodes) . 
Gyrotopy® New G2 Edison, NJ Shaker 
Shaker Brunswick 
Scientific Co. 
Inc. 
Spectronic® 20 Spectronic 400114 Rochester, NY Spectrophotometer 
Genesys Instruments 
BD Falcon 75 BD Biosciences 353134 Bedford, MA Tissue culture 
cm
2 Flask treated polystyrene 
sterile, non-
pyrogenic flask 
Costar 24 Well Coming Inc. 3524 Corning, NY Tissue culture 
Cell Culture treated polystyrene 
Cluster sterile, non-
pyrogenic 
Touch Mixer Fisher 231 Heights, NJ Vibrator 
Scientific 
BD Falcon 12.5 BD Biosciences 353107 Bedford, MA Tissue culture 
cm2 flask treated polystyrene 
sterile, non-
pyrogenic 
Redi-Tip™, Fisher 2119781 Fair Lawn, NJ Sterilized pipette tips 
101-lO00µL Scientific 
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Redi-Tip™, 1- Fisher 02681457 Fair Lawn, NJ Sterilized pipette tips 
200µL Scientific 
Fisherbrand® Fisher 136781 lD Fair Lawn, NJ Pipettes 
Disposable Scientific 
serological 
pipettes, 5 mL 
Fisherbrand® Fisher 1367811E Fair Lawn, NJ Pipettes 
Disposable Scientific 
serological 
pipettes, 10 mL 
Fisherbrand® Fisher 1367811 Fair Lawn, NJ Pipettes 
Disposable Scientific 
serological 
pipettes, 25 mL 
Fisherbrand® Fisher 055392 Fair Lawn, NJ Centrifuge tubes 
Disposable Scientific 
Centrifuge 
Tubes, 15 mL 
Fisherbrand® Fisher 055396 Fair Lawn, NJ Centrifuge tubes 
Disposable Scientific 
Centrifuge 
Tubes, 50mL 
Cuvets 1.5 mL, Fisher 14-385- Fair Lawn, NJ Cuvets 
Semimicro Scientific 942 
Replacement Fisher 13-681- Fair Lawn, NJ Replacement filters 
49 
filters Scientific 18C for Pipet-Aid 
Pasteur Pipets, VWR 14672- Marlboro, MA Pasteur Pi pets 
Plugged 412 
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Harvesting human osteoblast cells 
Collecting and treating the bone samples 
Osteoblast cells were harvested using a procedure modified from the one developed by 
Robey and Termine (1985) (Robey and Termine 1985), and Sobey and Berkman (1987) 
(Sodek and Berkman 1987), which consists of an explant procedure. The bone cells are 
allowed t~ grow out from bone explants obtained from adult tissues and they will retain their 
osteoblastic properties on subsequent culture. 
Human alveolar bone chips were obtained from healthy 18-25 year old patients of the 
Oral Surgery Clinic of the Boston University Goldman School of Dental Medicine coming in 
for a routine extraction of their impacted third molars. Informed consent was obtained from 
each patient according to the policy of the university. No extra procedure was needed in order 
to get the bone chips, since only wasted bone from the surgeries was collected. All the 
specimens were obtained from healthy patients with no metabolic or systemic diseases. 
After the specimens were collected (alveolar bone chips of 0.5~ 0.8 cm), they were 
placed in a 15 ml centrifuge tube containing 5 ml of cold PBS solution (phosphate buffered 
saline) and were taken to the lab to be treated. The specimens were treated within no longer 
than 2 hours from the time they were collected to the time they were placed in the culture 
flasks. Once in the lab, the procedure was done under a biological hood. Each bone specimen 
was first rinsed with a new solution of PBS and was then cleaned with a sharp #15 blade to 
remove all the fibrous tissues and blood residues. When the bone chip was showing a white 
appearance without visible fibers, it was minced into 3 to 4 smaller pieces. These pieces were 
placed into a 12.5cm2 polystyrene tissue culture flask containing 2 ml of culture medium. The 
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tissue culture flasks with the bone explants were maintained at 37°C with 5% CO2 and 
saturated humidity. The culture medium used for all experiments consisted of 40% DMEM 
(Dulbecco's Modified Eagle Medium) high glucose with L-glutamine, pyridoxine 
hydrochloride and without sodium pyruvate, 40% Fl2 Nutrient Mixture (Ham) with L-
glutamine, 10% FBS (Fetal Bovine Serum), and 10% of 10 times antibiotics (DMEM, 
Penicillin G sodium, Steptomycin sulphate and Fungazone ). This culture medium was then 
changed every day for 7 days and then every 3 days until the growing cells in the flask had 
reached confluency, which was in about 3 to 4 weeks. After a couple a days, the explants 
begin to attach to the flask, and it takes about 7-10 days before we can see some cells growing 
from the explants on the plastic surface under the microscope. 
Transferring the cells for second passage 
Once confluency was reached in the small 12.5 cm2small flask, the cells were 
transferred into a bigger flask of 75 cm2 using the following procedure. The explants were 
removed from the tissue culture flask and discarded along with the used culture medium. 
Then, 3ml of 0.25% Trypsin was added to the flask for 10 seconds. After 10 seconds, it was 
removed with a Pasteur pipette and another 3ml of trypsin was added for 7-10 minutes this 
time. For this period, the flask was put in the incubator at 37°C with 5% CO2 and saturated 
hu.rp_idity. Periodically, the cells were checked to see if they were detaching, floating and 
rounded up. Once they reached this stage, the cell solution was transferred to a 15ml 
centrifuge tube previously prepared with 7ml of the culture medium to stop the reaction. Total 
liquid volume at this time was 10ml. The tube was centrifuged at 1500 rpm for 7 minutes. 
The supernatant was poured off into the waste container and the cell pellet was resuspended 
with 10ml of fresh culture medium. The cell solution was then added to the 75cm2 
polystyrene tissu~ culture flask already containing 10ml of fresh culture medium. The flask 
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was incubated at 37°C with 5% CO2 and saturated humidity for 24 hours. The culture medium 
was changed the next day, and then every 3 days for 10 to 12 days or until the cells had 
reached confluency. 
Preparing the 24-well plates 
Five 24-well plates needed to be prepared 48 hours before the next step with the cells 
which would take place once the cells exhibited a confluent layer. The five well-plates were 
identical and prepared the exact same way: Forty eight hours before the last manipulations 
with the cells, an amount of SiO2 equal to 30% of the total weight of the MTA powder was 
added to the MTA powder and the two were put in a bottle and mixed using a tumbler mixing 
device on gentle cycle overnight. The same procedure was also done with the BIE powder 
which was added to the MT A following the same rules and the same percentage. The end 
result was a mixture ofMTA and 6%Si and 4.5% Ca. 
The next day, the MTA, the modified MTA with the SiO2 (MTA+Si) and the modified 
MTA with the BIE (MTA+BIE) were mixed according to the MTA manufacturer's 
instructions (ProRoot MTA, Dentsply) using the MTA water ampoules supplied by the 
manufacturer. The mixture obtained was condensed into the wells of the 24 well-plates to 
· form discs 15 .5 mm in diameter and 1 mm thick. Six discs were formed with the MT A in each 
plate, 6 with the modified MT A plus SiO2 and 6 with the modified MTA plus BIE leaving 6 
wells empty of material. The discs were allowed to set for 24 hours in the incubator at 37°C, 
5% CO2 and 100% humidity. The morning of the experiments, each plate was put under a 
glow discharge machine for a period of 4 minutes and was then positioned under the UV light 
of the hood for an additional 2 hours. 
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Seeding the cells into the wells 
After confluence was reached and the discs were ready, the trypsinization process was 
repeated. The culture medium was removed from the flask and discarded and 10ml of 0.25% 
trypsin was added to rinse the cells for 10 seconds. It was then also discarded and another 
15ml of trypsin was added to the flask for a period of 7 to 10 minutes in the incubator. 
During the incubating period, 7.5ml of fresh culture medium was added to two 15ml 
centrifuge tubes. The cells were periodically checked to see if they were detaching, floating 
and rounded up. Once they were fully detached, the 15ml solution was divided in two and 
7 .5ml was added to each centrifuge tube containing the culture medium. The two tubes were 
centrifuged at 1500 rpm for 7 minutes. After the centrifugation, the supernatant was poured 
off and discarded and the cell pellet was resuspended with 10ml of fresh culture medium for 
each tube. The cell solutions were then combined into a single 50ml tube. 
For the experiments, 1.5 X 105 cells/ml was the cell concentration that we wanted for 
standardization of culture conditions. In order to find out the cell concentration of the cell 
solution, the cells were counted using the hemocytometer method. A volume of 20µ1 of the 
cell solution was placed on the edge of the hemocytometer chamber and was drawn to it under 
the glass coverslip by capillary action. The hemocytometer chamber contains 9 major squares 
(making a 3 X 3 big square). The 1 OX objective of the microscope was selected and focused 
on the grid lines in the hemocytometer chamber. The cells were counted in the squares of the 
top and bottom comers right and left and in the one in the middle. The total was then divided 
by five and the cell concentration was calculated by the number of cells counted/ volume 
counted in ml (the number of cells we got divided by ten would give us the cell number in the 
solution by a 105 factor) (Freshney 1994). Depending of the cell number obtained, a dilution 
of the solution was sometimes needed to get a concentration of 1.5 X 105 cells/ml. 
54 
The way the study was designed, 4 wells containing the discs of the three different 
materials and 4 empty wells would receive cells from 4 different flasks ( cells coming from the 
explants of 4 different patients) and two wells for each category would be free of cells as a 
control ( only culture medium). -
Once the right concentration of cells was obtained, 1ml of the solution was put in each 
16 wells ( 4 in each category) and the 8 other were left empty. Then, the volume was adjusted 
to 2.5 ml with culture medium for each of the 24 wells. These cells were cultured for periods 
of 16 hours, 12 and 20 days to observe various degrees of osteoblast phenotypic behavior. 
The culture medium was changed every 3 days except after the first 16 hours where it was 
changed in 4 plates while the fifth one was used for cell attachment efficiency. The times 
chosen for these experiments were based on the temporal events of osteogenesis. Osteoblastic 
cell proliferation usually peaks around 12 to 18 days. In our experiments, cell attachment was 
evaluated at 16 hours, cell proliferation at 12 and 20 days and alkaline phosphatase and 
osteocalcin activity at 12 and 20 days. 
, The pH of the culture medium was also calculated every time the culture medium was 
changed (Day 1~16h, day 4, day 7, day 10, day 12 for plates used for testing at 12 days, day 
13 for the other plates, day 16, day 18 when differentiation media was added, and day 20). 
Measurement of cell attachment efficiency 
The cell attachment efficiency was detected by measuring the optical density of crystal 
violet dye that binds to the nuclei of the cell, which were attached to the disk of MTA and 
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modified MTA or to the plastic surface of the wells for the controls. Crystal violet dye is a 
basic dye with a maximum of 589-593nm light wave absorption (Lillie 1969). After 16 hours, 
the culture medium was removed from the 24 wells of one plate. The wells were rinsed twice 
with 1ml of PBS and then the cells were fixed with 1ml of 10% neutral buffered formalin 
solution for 30 minutes at room temperature. After 30 minutes, the formalin was removed 
and the wells were rinsed twice with deionized water and then fixed with 1ml of 0.2% crystal 
violet for another 30 minutes at room temperature. The crystal violet unbound stain was 
removed by extensive but gentle rinsing with deionized water until the rinsate was clear. In 
order to remove the bound stain, 500µ1 of 1 % Triton X-100 solution was added to each well 
and the plate was placed on a shaker for 5 minutes at 150 rpm. The saturated stain was 
collected and put in a cuvet for further measurement of the optical density using a 
spectrophotometer at 590nm light wave absorption. The process was repeated a second time 
and the saturated stain was added to the one collected before, bringing the total volume to 1 
ml in the cuvet. The optical density was then measured. The data for the 24 wells were 
collected and in order to convert the absorbance number obtained to -the number of cells 
attached, a conversion factor for the number of cells that were attached and the optical density 
of the crystal violet was done. 
Conversion factor for the crystal violet dye 
Before using the spectrophotometer to do some measurements of the optical density of 
the crystal violet, a standard curve was done using 1 :2 dilutions of the crystal violet starting 
with a solution containing 0.002g/ml and diluting it down to 0.0156µg/ml. This was done to 
find out the point on the curve were the solution becomes too concentrated and needs to be 
diluted in order to be read by the spectrophotometer. 
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To correlate the number of cells that were attached to the absorbance number given by 
the spectrophotometer, a conversion factor was needed. This was done using one 75cm2 
polystyrene flask containing cells that had reached confluency and by determining the cell 
concentration using the same technique as used to seed the cells into the wells. Cells were 
seeded into wells starting with 4.0 X 105 cells and diluted in 1 :2 dilutions. The cells were 
allowed to attach for 16 hours and were fixed and stained with crystal violet using the same 
method described above for cell attachment, giving an optical density measurement. This was 
used as a standard curve in order to find the slope to use as a conversion factor in order to 
convert optical density to cell number for subsequent crystal violet experiments. 
Screening of osteoblast phenotypic markers 
Assays for 1,25-dihydroxyvitamin 03 stimulated alkaline phosphatase activity 
(Kostenuik, Halloran et al. 1997; Rattner, Sabido et al. 1997) and osteocalcin release 
(Keeting, Oursler et al. 1992) are performed to detect the proteins that are characteristic of 
human osteoblast phenotype . 
Measurement of alkaline phosphatase activity 
Alkaline phosphatase activity was measured at the 12th and 20th day of experiments. 
Cel~s were cultured in 24-well plates with culture medium and at the 10th and 18th day, the 
culture medium in each well was replaced by 2ml of a differentiation medium. This medium 
consisted of 295.8ml of culture medium, 0.6ml of Charcoal-stripped FBS (0.2%), 3.0ml of 
IOOX Menadione solution, 0.6ml l,25(OH) 2 Vit. 0 3 and 0.030g of ascorbic acid. The pH had 
to be adjusted to 7 with chloridric acid or sodium hydroxyde.20. The cells were cultured to 
12 and 20 days and were then used to test for alkaline phosphatase activity. The medium was 
collected and frozen for further analysis of osteocalcin expression at 12 and 20 days. 
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In order to measure the alkaline phosphatase activity, spectrophotometric 
measurements at 405nm of the release of p-nitrophenyl phosphate were used. After removing 
the differentiation medium, cells were rinsed twice with PBS and fixed with 10% neutral 
buffered formalin for 30 minutes at room temperature and rinsed twice with PBS. Then 0.5ml 
of phosphatase substrate (p-nitrophenyl phosphate disodium salt hexahydrate) and 0.5ml of 
alkaline buffer were added to the cells in each of the wells and allowed to incubate at 37°C, 
5% CO2 at 100% humidity for 30 minutes. To stop the alkaline phosphatase reaction, 0.5ml 
of 0.05N NaOH was added to the wells. One milliliter of this solution was put in a cuvet and 
read at 405nm in a spectrophotometer. 
Measurement of Osteocalcin Activity 
A human osteocalcin kit (N-tact® Osteo SP from DiaSorin) for the quantitative 
determination of intact human osteocalcin 1-49 in serum ( or medium) was used. This assay 
utilizes two polyclonal antibodies that have been purified and isolated. Polystyrene beads 
were provided in the kit and were used as the solid phase on which the first antibody, specific 
for the amino terminus of the human osteocalcin, was bound. A solution containing the 
second antibody, specific for the car boxy terminus of . human osteocalcin, and labeled with 
iodine-125 was also supplied. Osteocalcin 1-49 is the only form of osteocalcin that will be 
bound by both the antibody on the beads and the 1251 labeled antibody. The complex formed 
on the beads was placed in vials with scintillation liquid and the analysis of the radioactivity 
was done by a scintillation counter. 
The procedure was as follows: 
To produce the standard curve, 20µL of Standard 0, A, B, C, D, E and 300µL of Tracer (red) 
of each solution was placed in scintillation vials and one vial was left with only the Tracer for 
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the total count. Then 20µL of unknown samples and 300µL of Tracer (red) was placed in 
other scintillation vials. All tubes were vorticed, one bead was dispensed in each tube ( except 
the total count tube) and the tubes were agitated on an orbital agitator at 190 ± 10 rpm for 2 
hours ± 5 minutes at 20-25 °C. The beads were washed by dispensing 1 ml of the wash 
solution and the procedure was repeated 2 more times. Then, the scintillation liquid was 
dispensed into each tube enough to cover the bead. The measurement of the radioactivity was 
done using a scintillation counter. The results were in counts per minute (CPM) and to find 
out the real values for my unknown samples, I had to subtract the value obtained from the 
value read in the vial with the 0 standard tube. 
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RESULTS 
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Results 
1. pH changes in the culture medium 
The culture medium was collected on day 1, 4, 7, 10, 12, 13, 16, 18 and 20 and the pH 
of the culture medium was measured for the controls ( each type of MT A had a separate 
control with only culture medium and no cells), the MTA, the MTA + Si, the MTA + BIE and 
for the wells containing the cells only. It was measured by using an Accumet Metro pH meter 
with the Accu-pHast combination electrode. For each group containing the cells and the 
material (MTA or MTA + Si or MTA + BIE) and for the cells only, 8 values were taken and 
the average was calculated. For the controls, only 2 values were taken for each group. In 
comparing all the groups, the control groups (no cells) and the groups with the cells had a 
similar trend, but the pH values were always higher for the control groups. Having cells 
lowered the pH of the culture medium. There was a drop in the pH at day 7. The values were 
the same as they were at the beginning at day 10, and then they slowly went down to reach 
their lowest point at day 19 and their highest point at day 20. Overall, the pH of the groups 
followed the pH of the culture medium. 
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pH Day 1 Day4 Day7 Day 10 Day 12 Day 13 Day 16 Day 19 
MTA 7,60±0.08 7,58±0.03 7,39±0.04 7,54±0.09 7,44±0.09 7,35±0.09 7,34±0.06 7,15±0.02 
Control MTA 7,73±0.02 7,72±0.03 7,52±0.02 7,74±0.04 7,77±0.06 7,68±0.04 7,66±0.07 7,37±0.04 
MTA + BIE 7,58±0.05 7,53±0.05 7,39±0.03 7,55±0.10 7,54±0.03 7,42±0.04 7,40±0.09 7,04±0.02 
Control BIE 7,72±0.03 7,74±0.05 7,54±0.01 7,80±0.02 7,78±0.02 7,72±0.01 7,77±0.04 7,43±0.07 
MTA+ Si 7,67±0.09 7,58±0.05 7,40±0.03 7,54±0.06 7,46±0.12 7,44±0.08 7,36±0.06 7,25±0.08 
Control Si 7,83±0.14 · 7,74±0.01 7,52±0.01 7,80±0.08 7,77±0.07 7,68±0 7,68±0.05 7,4±0.01 
Cells only 7,48±0.07 7,56±0.17 7,37±0.03 7,59±0.03 7,64±0.07 7,50±0.04 7,40±0.14 7, 17±0.05 
Control empty 7,54±0.01 7,56±0.04 7,50±0.01 7,75±0.03 7,76±0.09 7,70±0.04 7,60±0.02 7,37±0 
Table 1. The mean pH values of culture medium from wells containing the materials and the 
cells and the control groups (no cells). N=4 for all the test groups (MTA, MTA+BIE, 
MTA+Si and cells only). 
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Day 20 
7,59±0 
7,68±0.01 
7,61±0.04 
7,87±0.06 
7,69±0.07 
7,83±0.01 
7,65±0.01 
7,78±0.07 
Mean pH values of cell culture medium 
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Figure 1. The graph displays the pH values of culture medium exposed to MT A, MTA + Si, 
.,. MTA + BIB or an empty well and the cells and all these groups without cells. N=4 for each 
group at each time interval. N=4 for each test group at each time interval. 
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2. Cell attachment efficiency 
Cell attachment efficiency was determined by measuring the optical density of the 
crystal violet dye that was bound to the nuclear content of the cells that were attached to 
the cell culture plate in the cells only group, the MT A, the MTA + Si, and the MTA + BIB 
discs in the experimental groups after 16 hours of culture. The same prcedure was 
followed for the groups without cells and containing only the materials (used as controls). 
The values obtained from the control groups were subtracted from the values obtained 
from the groups with the cells to get the true value from the cells and to eliminate the error 
that could come from the part of the crystal violet that was bound to the materials. Then 
these values (absorbance at 590nm) were converted to cell numbers using a conversion 
factor. At 16 hours, we have significant evidence, using ANOVA at a<0.05, to show that 
the mean numbers of cells attached are not equal. Using a Tukey test as a multiple 
comparison test revealed that there was a significant difference between the cells only 
group and the MT A +BIE group. There was no significant difference among the MT A 
groups. The attachment percentage was calculated by comparing the 16 hour attachment 
of cells to the average amount of cells that were seeded into each well (about 1.5 x 105). 
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N Subset for alpha= .05 
1 2 
MATERIAL 
rrukey HSDa Cells 4 1,42E+05 
MTA 4 2,85E+05 2,85E+05 
MTA+Si 4 4,38E+05 4,38E+05 
MTA+BlE 4 4,71E+05 
I I I I 
I /Sig. I /'067 
,337 I I 
a Uses Harmonic Mean Sample Size= 4,000. 
Table 2. Means for groups in homogeneous subsets are displayed. 
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Average number of cells Percent attachment efficiency 
attached ± . standard deviation at 16 hours ( compared to at 0 
( x 105 cells) hours) 
MTA 2.85±1.53 190% 
MTA+BIB 4.71±0.49 314% 
MTA+Si 4.38±2.50 292% 
Cells only 1.42±0.30 95% 
ANOVA P= 0.032 
Table 3. The average number of cells attached at 16 hours and the percent efficiency of cells 
~ attached to MT A, MTA + Si, MTA + BIB, and the cell only group. 
Cell attachment at 16 hours 
8,00E+05 
.!? 
7,00E+05 
6,00E+05 oMTA a; 
u 5,00E+05 
-
■ MTA+BIE 0 4,00E+05 a; 
3,00E+05 o MTA+Si .c 
E 2,00E+05 □ Cells only :::::s 
z 1,00E+05 
0,00E+00 
Test groups 
Figure 2. The graph shows the attachment of cells to MTA, MTA + BIB, MT A + Si, and the 
cells only group at 16 hours of culture. N=4 for each test group. 
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3. 12 Day Attachment and Proliferation Rate 
The technique to determine the cell attachment at 12 days was the same as the one 
used to determine the cell attachment at 16 hours. The cells were fixed and stained with 
the crystal violet and the values obtained were subtracted from the values obtained from 
the control materials with no cells and then analysed. The same statistical analysis was 
done (ANOVA and Tukey's Procedure). In observing the cell attachment at 12 days of 
culture, we have significant evidence, a<0.05, to show that the mean numbers of cells 
attached are not equal. Using a multiple comparison test, a statistical significant difference 
was found between the control group (cells only) and the three other MTA groups. No 
statistically significant difference was found between the MTA + BIE and the MTA + Si 
and no statistically significant difference was found between the MT A + Si and the MT A. 
However, there was a statistically significant difference between the MTA + BIE and the 
MTA. 
Comparison of cell attachment at 12 days 
N Subset for alpha= .05 
MATERIAL 1 2 3 
rrukey HSDa Cells 4 2,24E+05 
MTA+BIE 4 8,57E+05 
MTA+Si 4 1,11E+06 1, 11 E+06 
MTA 4 1,30E+06 
Sig. 1,000 ,170 ,355 
a Uses Harmonic Mean Sample Size= 4,000. 
Table 4. Means for groups in homogeneous subsets are displayed. 
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Number of cell attached at 12 days (x 105 cells) 
MTA 12.99±2.09 
.MTA+BIE 8.57±1.21 
MTA + Si 11.11±1.94 
Controls ( cells only) 2.24±0.63 
ANOV A p=0 .000 
Table 5. Cell attachment over 12 days of culture. 
Cell attachment at 12 days 
1,60E+06 
1,40E+06 
!!l 1,20E+06 oMTA -a; 
(.) 1,00E+06 
-
MfA+BIE 0 8,00E+05 
'- D MfA+Si Cl) 6,00E+05 .0 
E 4 ,00E+05 a Cells only :::::, 
z 2 ,00E+05 
0,00E+00 
Test groups 
Figure 3. Cell attachment after 12 days of culture. Values .shown are means and standard 
deviation. N=4 for each test group. 
Proliferation rate 
Cell proliferation rate was determined by normalizing cell number at 12 days of 
culture to observe the proliferation of cells from 16 hours to 12 days. Therefore , 16 hours of 
culture was considered the baseline. In observing the proliferation rate at 12 days, • a 
statistically significant difference was found between the MT A + BIE and the MTA and also 
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between the cells only and the MTA. No statistically significant difference was found 
between the MT A + Si and the MT A and no statistically significant difference was found 
between the MTA + BIE, the MTA + Si and the cells only (controls). 
Proliferation rate of cells from 16 hours to 12 days 
MTA 5.54±2.69 
MTA+BIE 1.83±0.33 
MTA+Si 3.26±1.92 
Controls (cells only) 1.64±0.55 
ANOV A p=0.024 
Table 6. Cell proliferation rate over 12 days of culture. 
Statistical analysis of the proliferation rate at 12 days 
N Subset for alpha= .05 
1 2 
MATERIALS 
rTukey HSDa Cells ~ 1,64 
MTA+BIE ~ 1,83 
MTA+Si ~ 3,26 3,26 
MTA ~ 5,54 
Sig. ,544 ,275 
a Uses Harmonic Mean Sample Size= 4,000. 
Table 7. Means for groups in homogeneous subsets are displayed. 
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Proliferation rate at 12 days 
10,00 
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-
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Figure 4. Cell proliferation rate at 12 days of culture. Values shown are means and standard 
deviations. N=4 for each test group. 
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4. 20 Day Cell Attachment and Proliferation 
The technique to determine the cell attachment at 20 days was the same as the one 
used to determine the cell attachment at 16 hours and 12 days. The cells were fixed and 
stained with the crystal violet and the values obtained were subtracted from the values 
obtained from the control materials and then compared to the values obtained at 16 hours to 
get the proliferation rate. The same statistical analysis was done (ANOVA and Tukey's 
Procedure). In observing the cell attachment at 20 days of culture, we have significant 
evidence, a=0.05, to show that the mean numbers of cells attached are not equal. A 
significant difference was found between the cells only group and the three other MTA 
groups. No significant difference was found among the three other materials. 
Comparison of cell attachment at 20 days 
N Subset for alpha= .05 
1 2 
MATERIAL 
Tukey HSDa Cells 4 3,73E+05 
MTA+BIE 4 1,04E+06 
MTA+Si 4 1,08E+06 
MTA 4 1,09E+06 
Sig. 1,000 ,989 
a Uses Harmonic Mean Sample Size= 4,000. 
Table 8. Means for groups in homogeneous subsets are displayed. 
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Number of cell attached at 20 days (x 10:i cells) 
MTA 
MTA+BIE 
MTA+ Si 
Controls (cells only) 
ANOVA p=0.001 
Table 9. Cell attachment over 20 days of culture. 
Cell attachment at 20 days 
1,40E+06 
.!!! 1,20E+06 
c6 1,00E+06 (,) 
-
8,00E+05 0 
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10.88±2.41 
10.42±2.67 
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□ Cells only 
Figure 5. Cell attachment after 20 days of culture. Values shown are means and standard 
deviation. N=4 for each test group. 
Proliferation rate 
Cell proliferation rate was determined by ~ormalizing cell number at 20 days of 
culture to observe the proliferation of cells from 16 hours to 20 days. Therefore, 16 hours of 
culture was considered the baseline. In observing the proliferation rate at 20 days, there was 
no statistical significant difference among the four groups. 
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Proliferation rate of cells from 16 hours to 20 days 
MTA 4.55±2.27 
MTA+BIE 2.19±0.41 
MTA+ Si 3.44±2.87 
Controls ( cells only) 2.80±1.24 
ANOV A p=0.396 
Table 10. Cell proliferation rate over 20 days of culture. 
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Statistical analysis of the proliferation rate at 12 days 
N Sub set for alpha= .05 
1 
MATE RIAL 
Tukey HSDa MTA+B IE ~ ~.19 
Cell s ~ ~.80 
MTA +S i ~ 3,44 
MTA ~ 14,55 
Sig . ,358 
a Uses Harmonic Mean Sample Size= 4,000. 
Table 11. Means for groups in homogeneous subsets are displayed. 
Proliferation rate at 20 days 
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Figure 6. Cell proliferation rate at 20 days of culture . Values shown are means and standard 
deviations. N=4 for each test group. 
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5. Alkaline Phosphatase Activity at 12 days 
p-Nitrophenol Phosphate (pNPP) is a soluble substrate for use with alkaline 
phosphatase procedures. It is used for the determination of alkaline and acid phosphatase 
activity in physiological fluids and other aqueous solutions. This substrate produces a soluble 
end product that is yellow in color and can be read spectrophometrically at 405nm. 
Conversion from the absorbance values to the concentration of p-nitrophenol in moles was 
done using a known conversion factor (molar coefficient of extinction of the p-nitrophenol) 
(Shikita Met al., 1999). Using ANOVA analysis, we have significant evidence , a=0.011, to 
show that the mean numbers of p-nitrophenol concentration at 12 days (in M/100 000 cells) 
are not equal. A statistically significant difference was found between the cells only and the 
MTA and the MTA+Si. There was no statistically significant difference between the three 
MT A groups and between the MT A +BIE and the cells only group. 
ALP12 
N Subset for alpha = 
.05 
MATERIAL 1 ~ 
Tukey HSDa MTA f4 1,06E-05 
MTA+Si 4 1,85E-05 
MTA+BIE 4 2,44E-05 2,44E-05 
Cells 4 7, 13E-05 
Sig. ,826 ,055 
· a Uses Harmonic Mean Sample Size= 4,000. 
Table 12. Means for groups in homogeneous subsets are displayed. 
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Figure 7. ALP activity at 12 days of culture. Values shown are means and standard 
deviations for the four different groups. N=4 for each test group. 
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6. Alkaline Phosphatase Activity at 20 days 
Using the same protocol, alkaline phosphatase activity was measured at 405nm and 
the four groups were compared. Conversion from the absorbance values to the concentration 
of p-nitrophenol in moles was done using a known conversion factor (molar coefficient of 
extinction of the p-nitrophenol) (Shikita Met al., 1999). Using ANOVA analysis, we have 
significant evidence, a=0.000, to show that the mean numbers of p-nitrophenol concentration 
at 20 days (in M/100 000 cells) are not equal. Using a multiple comparison test (Tukey), a 
statistical significant difference was found between the cells only and the MTA groups. There 
was no statistical significant difference among the three MT A groups. 
ALP20 
N Subset for alpha = 
.05 
MATERIAL 1 2 
~ukey HSD8 MTA ~ 3,39E-11 
MTA+BIE 4 1,02E-10 
MTA+Si 4 1, 13E-10 
Cells 4 1,08E-09 
Sig. ,940 1,000 
a Uses Harmomc Mean Sample Size= 4,000. 
Table 13. Means for groups in homogeneous subsets are displayed. 
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Alkaline Phosphatase Activity at 20 days 
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Figure 8. ALP activity at 20 days of culture. Values shown are means and standard 
deviations for the four different groups. N=4 for each test group. 
78 
7. Osteocalcin expression at 12 days 
Osteocalcin 1-49 binds to a specific antibody which is labeled by 125!. The level of 
osteocalcin 1-49 was measured by the radioactivity present in the sample. The amount of 
osteocalcin in culture was expressed in ng/ml and then divided by the number of cells/ml to 
get values in ng per cell. Using ANOVA, we have significant evidence to show that the mean 
values of osteocalcin are not equal (p=0.000). Tamhane was used as a multiple comparison 
test, because we could not assume equal variances. Using that test, a statistically significant 
. difference was found between the cells only group and the three other MT A groups. No 
statistically significant difference was found between the MTA, the MTA +Si, and 
MTA+BIE .. 
Osteocalcin 
N Subset for alpha= .05 
1 2 
MATERIALS 
~amhane MTA 4 2.B0E-06 
MTA+Si 4 3.48E-06 
MTA+BIE 4 3.71 E-06 
Cell 4 25.10E-06 
Sig. 1.00 ,998 
a Uses Harmomc Mean Sample Size= 4,000. 
Table 14. Means for groups in homogeneous subsets are displayed. 
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Osteocalcin Expression at 12 days 
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Figure 9. Osteocalcin expression at 12 days of culture. Values shown are means and 
standard deviations. N=4 for each test group. 
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8. Osteocalcin Expression at 20 Days 
As previously described, osteocalcin 1-49 binds to a specific antibody which is labeled 
by 1251. The level of osteocalcin 1-49 was measured by the radioactivity present in the 
sample. The amount of osteocalcin in culture was expres·sed in ng/ml and then divided by the 
number of cells/ml to get values in ng per cell. Using ANOVA, we have significant evidence 
to show that the mean values of osteocalcin are equal. However, even if there was no 
statistical significant difference, the values for the cells only group were higher than for the 
three other MT A groups. 
Osteocalcin Expression at 20 days 
§ 25 ,00 .----------------, 
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J:. co 20 ,00 -+----------- ---+---__, ;c;, 
g ~ 15,00 -t-- ---------- -+-- ----l 
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Figure 10. Osteocalcin expression at 20 days of culture. Values shown are means and 
standard deviations. N=4 for each test group. 
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Discussion 
Many fields in dentistry and medicine are looking at ways to regenerate bone and to 
stimulate bone growth. In this in vitro study, we investigated the effects on osteogenesis of 
adding Silicon and BIB {Bioactive Inorganic Element) to the commercially available ProRoot 
white MTA (Dentsply) at a proportion of 30% of the total weight of the MTA. Normal 
human osteoblast cells were grown from bone explants to confluence, transferred and cultured 
on MTA discs for 16 hours, 12 days and 20 days. To investigate the reaction of those cells to 
the different surfaces, we looked at media pH, cell attachment efficiency, cell proliferation 
rate, alkaline phosphatase activity and osteocalcin expression. 
Silicon was added because previous studies have demonstrated its important role in 
osteogenesis. Carlisle in the early 1980s reported that a silicon-deficient diet would lead to 
• impaired collagen synthesis and defective skeletal structure in rats (Carlisle 1976; Carlisle 
1980; Carlisle 1980; Carlisle 1981 ). Dietary silicon increases the rate of mineralization. In 
the metabolically active state of the osteoblasts, levels of silicon appeared to be especially 
high. Keeting et al. (Keeting, Oursler et al. 1992) also demonstrated that the addition of 
zeolites A, a class of silicon-containing compounds, had a stimulatory effect on human 
osteoblast cell mitotic activity in a dose-dependant manner as well as on their alkaline 
phosphatase activity. This increase in cell proliferation was comparable to the degree of cell 
proliferation observed with potent growth factors. Chou et al. studied the osteogenic effects 
of Bioglass materials and came to the conclusion that a Si rich environment might · be 
responsible for increased osteogenic activity and higher levels of bone markers like 
osteocalcin (Chou, Al-Bazie et al. 1998). This stimulating effect of silicon is dose-dependant. 
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The BIE material added to the MT A in this study is a form of bioglass material that 
belongs to the Class A of Bioactives glasses. It has the advantage of being not only 
osteoconductive, but also osteoproductive because of the formation of a biologically active 
hydroxycarbonate apatite layer (HCA) on the surface of the glasses. This layer would 
stimulate bone formation by attracting osteoprogenitor cells and osteoblasts. In contact with 
body fluids, there is also formation of a silica gel layer, providing soluble silicon and possible 
ion exchange for the cells. 
Environmental pH may play a significant regulatory role in osteoblastic function. 
Therefore, in this experiment, the pH of the culture was collected at different time intervals to 
be analysed. The pH of the test materials as well as the pH collected from the controls (no 
cells cultured on the tests materials) was measured. Overall, the control groups and the test 
groups with cell cultures had a similar trend, but the pH values were always higher for the 
control groups. The control values were between 7.3 and 7.9. Test groups values were 
between 7.0 and 7.7. This could be explained by the fact that growing cells release 
metabolites such as lactic acid that lower the pH of the culture medium (Reeve, Arlot et al. 
1988). Also, osteoblasts are attempting to regulate their environmental pH and move it 
towards a more "physiologic" pH range of 7.2-7.4 (Kaysinger and Ramp 1998). This was 
observed in our study. The empty plate with only culture medium had a higher pH (pH 7.6-
7.8) than all the plates with cells or the cells and the test materials (pH 7.2-7.6). Kaysinger et 
al. also demonstrated in their study that collagen synthesis and alkaline phosphatase activity 
increase with increasing pH. When those makers are used to determine osteoblastic activity, 
an increase in this activity can be seen when the pH is between 7.0 and 7.6. Cell growth will 
stop when pH falls from pH 7.0 to 6.5, and the cells will loose their viability between pH 6.5 
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and 6.0. The study was carried out over a 20 day period, and for all the pH measurements 
made, the tests groups were always situated within that range (7.0-7.6) , a good indication that 
osteoblastic activity was possible. Another observation that was made is that the pH 
measurements of all the groups were following the same trend as the pH trend observed for 
the culture medium only. Variations of the pH of the culture medium were seen and those 
variations would affect all the other groups. Culture medium is supplemented with bovine 
serum containing a complex of proteins and molecules and is kept in an incubator at 37°C and 
5% CO2• The proteins act as a buffer for the culture, but over time , there is a degradation of 
proteins leading to some variations in the pH. 
Cell attachment efficiency 
Cell attachment efficiency was determined by measuring the optical density of the 
crystal violet dye that binds to the nuclei of the cells which were attached to the plates or to 
the test materials. Crystal violet is a basic dye with maximum 589-593nm light wave 
absorption (Lillie 1969). It was initially used for analysis of cytotoxicity, but Gillie et al. in 
1986 (Gillies , Didier et al. 1986) described an alternative procedure to allow estimation of cell 
number in growing cultures. 
The results of this study revealed that there was no significant difference between the 
cells attached to the MT A, the MT A +Si and the MT A +BIE at 16 hours, but there was a 
significant difference between the cells only group and the MTA+BIE group (the number of 
cells attached to MTA+BIE group was significantly higher). When examining cell 
proliferation , it is helpful to review the cell cycle. Bacteria can divide as fast as every 20 
minutes. However, normal human cells can only divide once or twice daily. There are 4 · 
important steps in this cell cycle. G 1, which usually lasts 6h to several days, S for the DNA 
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replication and which lasts about 8h, G2, which usually lasts 2h and M for the mitosis, which 
usually last lh. 
The experiment to determine the cell attachment efficiency was done after 16 hours 
from the initial plating of the cells. This time frame was chosen to allow the cells to attach, 
but not to proliferate. The results however showed a percentage of cell attachment efficiency 
that exceeded 100% for the MTA groups, a sign of very early proliferation or residual crystal 
violet stain from the test materials. Values higher than 100% are unlikely considering the 
temporal events of the cell cycle in which it takes at least 24h for a cell to duplicate. In this 
study, control wells containing only the test materials without the cells were used to find out 
about the amount of crystal violet that was absorbed by those test materials and those values 
were subtracted from the values obtained from the wells containing both the test materials and 
the cells. It should have eliminated the possible errors coming from the test materials. One 
possible explanation is that maybe with the addition of cells on the surface of the MTAs, there 
was a change in the surface topography or maybe a chemical reaction occurred (HCA layer 
forming) (Hench and Wilson 1984), allowing the surface to absorb more crystal violet than 
did the test materials only. Cell shape can be markedly influenced by surface topography of 
the substrata and subsequently influence cell growth. Past literature indicates that substratum 
surface topography alters cell shape and modulates fibronectin at the transcriptional and post-
transcriptional levels (Chou, Firth et al. 1995) and that the surface chemistry of biomaterials 
can selectively regulate the cellular behaviour at the molecular level (Chou, Firth et al. 1998). 
Another factor that could affect the absorption of crystal violet by the MTA groups is the 
solubility of those materials when cells are seeded on their surface. The addition of cells 
might decrease the solubility of the material by creating a protective layer and then it would 
retain more of the dye. Previous studies were also performed with the grey MT A and this 
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study was done with the white form of MTA. Since it has been reported that a change in the 
surface topography occurs when the white MT A sets compared to the grey MT A, this might 
have had an effect on the results obtained (Perez, Spears et al. 2003). Because of those 
possible confounders, for the analysis of the results, cell proliferation rate will be a more 
accurate measurement than the cell attachment numbers. In Dr. Tam's thesis where 15%Si 
was added to the MTA, no statistically significant difference was found between the MT A, 
the modified MTA with 15%Si and the control. Perhaps this difference between the two 
studies can be attributed to the fact that white MT A was used in the present study whereas 
grey MTA was used in the previous study. White MT A, with its different surface topography 
may retain more of the crystal violet dye, creating some variations in the results. 
Cell proliferation 
In previous studies, the importance of silicon on cell proliferation has been 
demonstrated (Keeting, Oursler et al. 1992; Matsuoka, Akiyama et al. 1999). Keeting et al. 
(Keeting, Oursler et al. 1992) studied the effect of a silicon-containing compound (Zeolite A) 
on normal human osteoblast-like cells for a 48h period. The zeolite A induced a dose-
dependant increase in DNA synthesis, an increase in alkaline phosphatase activity, osteocalcin 
release and the secretion oflatent TGF-~. 
They concluded that ZA induces the proliferation and differentiation of cells of the 
osteoblast lineage. Therefore, silicon ions released in physiologic solution may play a role in 
the regulation of osteogenic behavior. It was also demonstrated that silicon and other ions 
enhanced cell proliferation in a dose-dependant manner. 
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In our study, at 12 days, the cell proliferation rate over the MTA samples was 
statistically greater than the cell proliferation rate of the cells only and the MTA+BIE, with no 
significant difference with the MTA+Si. However, at 20 days, there was no statistically 
significant difference among the groups. And when comparing the numbers at 12 and 20 
days, only the cells only group has a positive proliferation rate at 20 days (might not be 
significant) compared to 12 days. Either the cells over the MTA groups stopped proliferating 
between 12 and 20 days to start differentiating or some cells were lost. In Dr. Tam's thesis 
where 15%Si was added to the MT A, no statistically significant difference were observed 
between the MTA and the modified MTA with 15% Si, but they were significantly different 
than the control group with the cells only. This is a similar trend that what was observed in 
our study, but it was not significant in our study. 
Some studies reports that cells grown over bioactive materials have a peak ALP 
between day 8 and day 11 (El-Ghannam, Ducheyne et al. 1997) (Dieudonne, van den Dolder 
et al. 2002) and that cell grown on a culture dish have a peak ALP around day 15 (Owen, 
Aronow et al. 1990). The fact that the proliferation peak occurs a day or two before the ALP 
peak, could explain why the proliferation rate has decreased from day 12 to day 20, especially 
for the MTA groups. Their proliferative peak probably occurred before the proliferative peak 
for the cells only group. 
Another possible explanation for the decrease in cell number between day 12 and day 
20 is that the MT A surface might induce programmed cell death after synthesis of 
extracellular matrix on its surface (El-Ghannam, Ducheyne et al. 1997). 
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The lack of attachment of primary osteoblasts on the white MT A surface after a period 
greater than 13 days could be another factor explaining the results. The reduction in the iron 
component of the white MT A could contribute to osteoblasts not remaining attached to its 
surface (Perez, Spears et al. 2003). 
Also, at 12 days, the proliferation rate of the MTA was greater than the proliferation 
rate of the MTA+BIE. This could be explained by the differences in surface topography of 
the 2 materials (particles ofBIE observed in the SEM were larger) or by the fact that bioactive 
materials might release more Si ions, creating a selection of the cells staying attached to their 
surface. More cells undergo apoptosis, but the remaining cells are more capable of 
differentiating and expressing the osteoblast phenotypes (Xynos, Edgar et al. 2000). 
• Alkaline Phosphatase Activity 
Alkaline phosphatase is the most prominent enzyme associated with osteoblastic 
differentiation. It is a phenotypic bone marker used to identify and measure the 
developmental and differentiating sequence of osteoblasts. Studies have demonstrated that 
alkaline phosphatase can be found in preosteoblasts and its activity increases when there is a 
shift to a more differentiated state. 
In our study, ALP activity was much greater at 12 days than at 20 days for all the 
groups. At 12 days, there was no statistically significant difference among the MTA groups 
and between the MTA+BIE and the cells only group. The only significant difference was 
found between the cells only group and the MTA, and the MT A +Si groups. The cells only 
group had the greater ALP activity. 
In Dr. Tam's thesis where 15%Si was added to the MTA, the same findings were noted. 
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Previous studies have demonstrated that peak ALP occurs more rapidly when cells are 
grown onto bioactive glasses. For Matsuoka et al., the higher ALP activity occurred at 4 and 
7 days whereas it had decreased by the tenth day. For El-Ghannam et al. (El-Ghannam, 
Ducheyne et al. 1997), ALP activity had a marked increase from day 7 to day 11 and then the 
levels returned to numbers similar to those observed at day 1. When cells are grown in the 
absence of bioactive glasses, they usually have a peak ALP at 15 days (Owen, Aronow et al. 
1990). 
Those studies can explain why ALP activity was greater for the cells only group at 12 
days than for the other MTA groups. By doing the experiments at 12 days, we probably 
missed measuring the peak ALP for the MTA groups, because it probably occurred around 7 
~ to 10 days. However, we were closer, at 12 days, to the peak of ALP activity for the cells 
only group. With those results, we can say that cells grown onto MTA, MTA+BIE and 
MTA+Si differentiate earlier than cells grown on culture plates. Matsuoka et al. in their study 
found out that Si did not stimulate proliferation of the cells, but enhanced their ALP activity. 
Some studies have demonstrated that Si release increases ALP activity in cells in a dose-
dependant manner (El-Ghannam, Ducheyne et al. 1997; Chou, Al-Bazie et al. 1998; 
Matsuoka, Akiyama et al. 1999). 
By day 20, ALP activity was well beyond its peak which explains why the numbers 
are much lower. 
ALP activity is dependant on the degree of crystallinity of the calcium phosphate layer 
formed on the glass surface (El-Ghannam, Ducheyne et al. 1997). Therefore, if the surface 
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were conditioned for a longer time with simulated tissue fluid prior to seeding the cells, this 
could account for the increase ALP activity. 
Osteocalcin 
Osteocalcin is one of the best characterized non-collagenous proteins. Osteocalcin 
deposition may be a relatively late event in the process of bone formation, because it is not 
present in preosteoblasts. Studies have demonstrated an increase in osteocalcin expression at 
the onset of mineralization (Owen, Aronow et al. 1990) and at a late stage of differentiation 
(post-proliferative osteoblast stage) (Stein, Lian et al. 1996). It appears concomitantly with 
growth arrest. 
In our study, osteocalcin expression at 12 days was significantly higher for the cells 
only group than for the MTA groups. There was no statistical difference among the MTA 
groups. At 20 days, there was no statistical significant difference among the all the groups, 
but numbers were higher for the cells only group. When comparing the results at 12 and 20 
days, osteocalcin expression is higher for the cells only group at 12 days and numbers for the 
MTA groups are similar at 12 and 20 days. 
In Dr. Tam's thesis where 15%Si was added to the MTA, completely opposite 
findings were noted regarding osteocalcin expression. Since Dr. Tam's numbers for 
osteocalcin levels were so high and are very far away from normal osteocalcin cell 
production, it was decided that we would rely on other studies to compare our results. 
It has been demonstrated in the past that osteocalcin expression usually peaks around 
day 20 when the cells are grown on culture dishes (Owen, Aronow et al. 1990). In our study, 
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since the values for the cells only group are lower at 20 days than at 12 days, the peak in 
osteocalcin expression possibly occurred earlier, somewhere between 12 and 20 days. For the 
MT A groups, it seems that growing them on bioactive materials has considerably modified 
their temporal events creating an ALP activity peak somewhere between 7 and 11 days. 
Therefore, it is possible that their osteocalcin peak might have occurred considerably 
earlier too, before day 12. In that case, the levels of osteocalcin would have stabilized to the 
levels measured in our study. 
Adding 30% BIE and 30% Si to the MT A did not show a significant effect on cell 
culture, cell attachment and proliferation, alkaline phosphatase activity and osteocalcin 
expression when compared to conventional MTA. However the sample size ( 4 for each group 
and for each time interval) was relatively low and therefore some results had a high standard 
deviation. By increasing the sample size it would be possible to decrease the standard 
deviation and then to see some significant differences. 
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CONCLUSIONS 
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Conclusions 
1. Media pH 
Growing cells onto the test materials lowered the media pH; 
pH values were mostly influenced by the pH of the culture medium, which acted as a 
buffer. 
2. Cell attachment efficiency 
Cells seemed to attach better when seeded on MTA +BIE, although values were not 
statistically different then values recorded for the MT A and the MT A +Si. 
3. Cell proliferation rate 
MTA had slightly higher proliferation rate at 12 and 20 days, although there were no 
statistically significant differences among the groups at 20 days; 
The proliferation rate of the cells decreased between 12 and 20 days, allowing them to 
better differentiate. 
4. Alkaline phosphatase activity and osteocalcin expression 
When cells were grown onto the MTA, MTA+Si and MTA+BIE, there peak ALP 
activity and osteoclcin expression were passed at the 12 day time frame chosen for 
analysis, indicating early differentiation of the cells. Greater values were noted for 
ALP activity and osteocalcin expression at 12 and 20 days. 
5. Even if the test materials showed some differences in their osteogenic potential, no 
conclusion could be drawn as to which material had the greatest osteogenic potential. 
Based on the results of this in vitro study, it was determined that the MTA group and 
the two modified MT As had a higher cell attachment efficiency and proliferation rate than 
cells grown in the absence of materials. Cells grown in the presence of the MT A group and 
the two modified MT As had a lower ALP activity and osteocalcin expression, but it could be 
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due to the time intervals chosen for the study. Since the MTA materials seem to stimulate an 
earlier differentiation of the cells, earlier time intervals should be added to future studies. 
For this study, the MTA group and the two modified MTAs exhibited osteogenic 
effects on normal human osteoblast cells. These findings are supported by previous studies 
which demonstrated that MT A is biocompatible and stimulates osteoblast cell expression and 
growth. 
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FUTURES STUDIES 
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Futures studies 
For futures studies, since it has been demonstrated that surface conditioning of 
bioactive glassi increase its ALP activity, it would be interesting to condition the surface of 
the material with simulated tissue fluid (like culture medium) prior to seeding the cells onto 
its surface. 
Also, since it has been demonstrated that there is a possible growth arrest around day 7 
of the primary osteoblasts when grown onto white MT A (Peres et al.), futures studies could be 
done on grey MT A instead of white MTA. 
When using the crystal violet technique to evaluate cell attachment efficiency and cell 
proliferation rate, there might be a confounder effect created by the difference in solubility of 
the MT A groups whether they have cells growing onto their surface or not. It would be 
interesting to evaluate the differences in solubility of the materials when they are in the 
presence of culture medium only, and with culture medium and cells growing onto their 
surface. 
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